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Coronary stent placement is a routine treatment of coronary artery disease, the 
leading cause of death worldwide. Intravascular Optical Coherence Tomography (IVOCT) 
is a superior imaging assessment technique in coronary stenting. To characterize IVOCT 
artifacts, phantom blood vessels were constructed and metallic and bioabsorable coronary 
stents were deployed with and without phantom neointima. High resolution Micro-CT 
images of the stent strut were recorded as a gold standard and utilized to create a three-
dimensional representation of a strut that was imported into computer optical simulations. 
Simulated IVOCT images were computed that include the IVOCT catheter, light reflection 
from stent struts with varying neointimal thickness and scattering in the vessel lumen. The 
simulation results along with IVOCT images of the phantom vessels were utilized to 
elucidate the mechanisms underlying the “sunflower effect”, bending of stent struts toward 
the imaging catheter and “merry-go-round” effect, variable apparent strut size of metallic 
stents. Atomic force microscopy was used to examine surface properties of metallic and 
bioabsorbale stents, revealing sources of the distinctive appearance of bioabsorable stents 
in IVOCT images. The model formed a basis to develop a correction algorithm to remove 
stent artifacts in clinical IVOCT images. 
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Chapter 1: Introduction 
The objective of my research is to characterize and correct artifacts that arise when 
imaging stents in coronary arteries with intravascular optical coherence tomography 
(IVOCT).  In 2008, coronary artery disease (CAD) caused almost 1 of every 6 deaths in 
the United States. Over the next two decades, projected costs for all cardiovascular diseases 
are expected to increase 61% with CAD accounting for almost 40% [1]. Three types of 
stents for CAD have been introduced over the last two decades: these include 1) bare metal 
stents; 2) drug eluting stents; and 3) bio-absorbable stents. After stent deployment, 
assessment of stent apposition and tissue growth over struts requires diagnostic imaging. 
Although intravascular ultrasound (IVUS) has been utilized to assist with stenting coronary 
arteries, resolution (80-120 um) is limited. In comparison to IVUS, IVOCT provides higher 
image resolution by one order of magnitude (10-15 um) making this technique a preferred 
assessment technique in coronary stenting of coronary arteries. Clinical use of IVOCT to 
assess coronary stenting will benefit from the characterization and correction of various 
artifacts. Specific aims of my research include: 
 Describing the underlying mechanism of sunflower artifact - bending of stent struts 
towards the catheter at eccentric positions in the vessel lumen  
 Presenting an accurate and verified method of strut apposition measurement  
 Evaluation of IVOCT in neointima thickness measurement 
 investigate merry-go-round effect - elongation of the stent struts - due to residual 
blood not completely removed by flushing and neointimal coverage over the stent  
 Identifying the mechanism(s) for differences in IVOCT images of bioabsorbable 
vs. metallic stents 
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 Developing an artifact correction algorithm for metallic stents which replaces the 
apparent stent struts rendered in IVOCT images recorded during a pullback with 
the actual stent structure obtained by Micro-CT imaging. 
ORGANIZATION OF THE DISSERTATION  
Chapter 2 “Coronary artery disease: diagnostics and treatments” provides an 
overview to coronary artery disease and coronary stents. A brief history of advancements 
in different stent types, as well as imaging modalities utilized during stent deployment are 
presented. Principles of IVOCT imaging and its applications in stenting are discussed. 
Lastly, imaging artifacts associated with IVOCT images are introduced which motivates 
this work.   
Chapter 3 “Models for studying IVOCT artifacts” describes the two models that 
were created; a physical blood vessel model and a computer model. Construction of 
phantom vessels and stent deployment are included, followed by description of Micro-CT 
and IVOCT imaging protocols. Computer model was created by defining an IVOCT 
catheter and importing a strut model in ZEMAX, non-sequential ray tracing was performed 
and ray data was imported to MATLAB for analysis.  
Chapter 4 “IVOCT measurement of size and apposition of metallic stents” begins 
with investigating the factors contributing to variation in apparent size of struts in IVOCT 
images. Sunflower effect is reproduced in IVOCT images of phantom vessels and 
simulated images in the computer model which is utilized to ellucidate the origin of this 
artifact. Knowing the actual position and orientation of struts in the models, an accurate 
method of malapposition measurement is proposed.   
Chapter 5 “IVOCT imaging of coronary artery metallic stents with neointimal 
coverage” explores neonitimas in IVOCT images. Fabrication of phantom neointima which 
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covers the stents deployed within phantom vessels is described. IVOCT and Micro-CT 
images of phantom vessels with neointima are utilized to evaluate acuracy of IVOCT in 
neonitima thickness measurement. Effect of luminal scattering on detection of thin  
neonitma is examined. Additionally, merry-go-round and sunflower effects in presence of 
thick neointima are examined. 
Chapter 6 “Bioabsorbable stents” explores the current status of bioabsorbable stent 
development. IVOCT and Micro-CT images of bioabsorbable stents are used to describe 
the appearance of stent struts. To compare bioabsorbable and metallic stents, surface 
optical properties are determined using atomic force microscopy and measurement of 
refractive index. 
Chapter 7 “Metal stent artifact correction algorithm” describes developing an 
algorithm which replaces the apparent stent struts in IVOCT pullback images with the 
actual stent structure obtained by Micro-CT imaging. Creating stent database from Micro-
CT images is described which formed the global coordinate system. A helix function is 
generated inside the stent which represents the position and direction of A-scans and is 
modified by catheter position and orientation. Stent positions that are recorded by the helix 
in local coordinate system form simulated pullback and is transformed into global 
coordinates using stent position and orientation. Simulated pullback and transformation 
parameters form an objective function that is utilized by Levenberg-Marquardt algorithm 
to fit to the IVOCT pullback data.  
Chpater 8 “Conclusions and discussions” summarizes the results of this work and 
outlines future studies. 
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Chapter 2: Coronary artery disease: diagnostics and treatments 
CORONARY ARTERY DISEASE 
Coronary artery disease (CAD), also called coronary heart disease, is a leading 
cause of death in United States. Statistics of 2005-2008 show that 16.3 million people have 
CAD, about 8.3% of males and 6.1% of females [1]. CAD resulted in 405,309 deaths in 
2008, accounting for approximately 1 of every 6 deaths in the United States. Costs for all 
cardiovascular diseases are projected to increase 61% (from $171.7 billion to $275.8 
billion) between 2010 and 2030 and CAD is estimated to account for approximately 40% 
of total costs [1]. 
CAD is the atherosclerosis of the coronary arteries in which plaque builds up within 
the walls of the arteries that delivers oxygen to the myocardium and consist of blood-borne 
inflammatory and immune cells, vascular endothelial and smooth-muscle cells, lipids, and 
debris [2]. The presence of plaque buildup results in the narrowing of the arterial lumen - 
called stenosis - and the restriction of blood flow. Over time, reduction of oxygen-rich 
blood weakens the myocardium, however; the sudden rupture of these vulnerable plaques 
are the cause of heart attacks.  
 
Figure 2.1:  a) healthy coronary artery, b) stenotic coronary artery [3] 
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Treatment for CAD usually involves lifestyle changes, medications or medical 
procedures [4]: 
 Lifestyle changes include: quitting smoking, eating healthy foods, a regular 
exercise routine, weight loss, stress reduction. 
 Medications may slow the disease's progress or ease the symptoms and 
include cholesterol-lowering medications to decrease the primary material 
that deposits in the lumen of coronary arteries, blood thinners to reduce 
blood clotting capability, beta-blockers to decrease blood pressure.  
 Bypass surgery: coronary artery bypass grafting is a heart procedure in 
which a section of a healthy blood vessel is connected (grafted) to coronary 
artery slightly past the site of the blockage to create a new path for blood to 
flow around (bypass) the blockage in the artery. 
 Percutaneous coronary intervention (PCI): minimally invasive treatments to 
restore and improve blood flow, including:  
o Coronary balloon angioplasty: a balloon pushes back plaque and 
widens the artery, enabling blood to flow at a normal rate.  
o Stenting: a stent is an expandable, mesh-like cylindrical structure 
which provides structural support to maintain the artery open, 
allowing normal blood flow to the myocardium 
STENT ADVANCEMENT 
The first bare metal stent, Johnson & Johnson Palmaz-Schatz Balloon-Expandable 
Stent was introduced in the United States in 1994 [5]. While bare metal stents have been 
successfully used in treatment of CAD, some limitations associated with this technique 
have been identified, one of which is restenosis. After stent deployment, new tissue grows 
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inside the stent, developing a tissue lining over the stent which allows a smooth blood flow 
over the stented area. Later, however; the body’s inflammatory response results in scar 
tissue formation underneath the new lining, which in about 25% of patients, obstructs the 
blood flow and produces an important blockage [6]. This condition, called in-stent 
restenosis, is typically seen 3 to 6 months after the stent deployment procedure [6]. 
Prevention of in-stent restenosis is achieved by a new generation of “drug-eluting” stents. 
Endeavor® Zotarolimus-Eluting Coronary Stent System was the first drug eluting stent 
approved by FDA in 2008 [7]. The surface of these metallic stents is covered by a polymer 
which releases immunosuppressant pharmaceuticals such as Sirolimus and paclitaxel over 
time to reduce scar tissue growth and prevent restenosis. Despite the widespread use of 
drug-eluting stents, there remains the issue of implantation of a permanent metallic 
intravascular prosthesis and the long-term body reaction. Stents composed of 
bioabsorbable materials represent an alternative modality which meets the short-term need 
for vessel scaffolding and avoidance of the potential long-term complications of metallic 
stents [8]. While the IGAKI-TAMAI stent, Kyoto Medical Planning Co., Ltd. obtained CE 
mark approval in 2007, bioabsorbable stents are still under clinical trial studies in the US 
required for FDA approval [9]. 
 
Figure 2.2:  a) restenosis in BMS, b) Thrombosis in DES [10]  
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STENT DEPLOYMENT PROCEDURE 
Stent deployment is performed in a catheterization clinic. Angiography is first 
utilized to assess the location and estimate the extent of the blockage and afterwards, IVUS 
is used to determine the luminal area of stenosis for stent sizing. Stents are packaged from 
the manufacturer in collapsed form, placed around a balloon at the tip of a catheter. 
Catheter is inserted through a small surgical opening in a blood vessel in the groin and 
guided to the stenotic artery. After positioning the still collapsed stent adjacent to the 
plaque region, balloon is inflated to a specified pressure which in turn expands the stent to 
a certain size. Balloon is deflated and removed along with the catheter, leaving the stent 
pressing against the plaque to keep the artery open and restore normal blood flow.  
 
Figure 2.3: Stent deployment procedure: a) restricted blood flow in a stenotic artery, b) 
balloon on tip of catheter is inflated to expand the stent, c) expanded stent 
after removing catheter and deflated balloon [4] 
 8 
INTRAVASCULAR OPTICAL COHERENCE TOMOGRAPHY 
Intravascular Optical Coherence Tomography (IVOCT) is a newly developed 
imaging modality that provides high resolution, cross sectional images of vascular 
structures.  
OCT principles 
The principle of OCT imaging is analogous to that of ultrasound imaging except 
that OCT uses light waves. The advantages of OCT over sound originate in the much 
shorter wavelength and substantially higher frequency. An optical beam is scanned across 
the tissue, measuring the echo time delay and intensity of backscattered light from tissue 
structures [11]. Since the speed of light is extremely fast, the echo time delay cannot be 
measured directly, which requires using interferometry techniques. One method is low-
coherence interferometry which measures the echo time delay and intensity of 
backscattered light by interfering light from a sample with light that has traveled a known 
reference path length and time delay [12]. Measurements are performed using a Michelson-
type interferometer where light from a source is directed to a beam splitter; one beam is 
incident on the sample, while the second beam travels a reference path with variable path 
length. The backscattered light from the sample is interfered with reflected light from the 
reference arm at the interferometer output. Interference occurs when the two path lengths 
match within the coherence length of the light. The measured echo time delay and intensity 
of the backscattered light yield an axial backscattering profile called A-scan (Figure 2. 4-
a). The incident beam is scanned at several lateral positions to produce a two dimensional 
data set, called a B-scan which represents a cross section of the tissue (Figure 2. 4-b).  
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Figure 2.4: a) One A-scan, intensity measured vs. depth, b) collection of A-scans form a 
two-dimensional B-scan which represents a cross-sectional view of the tissue. 
The axial resolution is determined by the coherence length of the light source. The 
interference signal is the auto-correlation of the light source where the envelope is 
equivalent to the Fourier transform of the power spectrum. Since coherence length is the 
spatial width of the auto-correlation function, it is inversely proportional to the width of 
the power spectrum. The axial resolution ∆𝑧 for a source with a Gaussian spectral 
distribution is given by: 
∆𝑧 =
2 𝑙𝑛2
𝜋
𝜆2
𝛥𝜆
  (2.1) 
where ∆𝑧 and 𝛥𝜆 are the full-width-half-maximum of the auto-correlation function and 
power spectrum respectively, and 𝜆 is the center wavelength. The transverse resolution is 
determined by the focused spot-size defined by: 
∆𝑟 =
4𝜆
𝜋
𝑓
𝑑
  (2.2) 
where 𝑑 is the spot-size on the objective lens and 𝑓 is the focal length. In addition, the 
transverse resolution is also related to the depth of focus which is two times the Raleigh 
range as given by: 
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2𝑧𝑅 =
𝜋𝛥𝑥2
2𝜆
  (2.3) 
IVOCT imaging  
IVOCT catheter is directed to the area of interest through a guide wire and IVOCT 
signal is recorded while the catheter is pulled back in the posterior to anterior directions. 
The catheter also rotates during data acquisition which combined with translation results 
in imaging a helical trajectory. However, the presence of blood inside the vessel lumen will 
strongly attenuate the IVOCT signal due to light scattering. To overcome this problem, a 
fluid - usually a contrast agent - is flushed around the catheter to clear the blood, eliminate 
light scattering and enable the light to travel from catheter to the blood vessel lumen and 
backscattered light into the catheter. Once the pullback is complete, blood flow is restored. 
IVOCT uses near-infrared light of 1320 m wavelength, where hemoglobin absorption is 
low and scattering is reduced, allowing deeper penetration in tissues. Resulting images 
provide resolution of 10-20 m and a penetration depth of 2-3 mm. 
 
Figure 2.5: Imaging a stenotic artery by IVOCT: catheter is directed to the area of interest 
through a guide wire, contrast clears the blood and IVOCT signal is recorded 
while the catheter rotates and is pulled back [13]. 
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Since A-scans are recorded while the catheter simultaneously rotates and translates, 
two successive A-scans correspond to an angular sweep over the tissue and therefore 
IVOCT B-scans represent a polar image. To obtain IVOCT images that provide cross-
sectional view of a blood vessel a polar to rectangular conversion is required (Figure 2.6). 
Recorded A-scans during each revolution are distributed evenly over 2𝜋, giving each A-
scan the angle of 
𝜃𝑖 =
2𝜋 𝑛𝑖
n
  (2.4) 
Where 𝑛𝑖  is the A-scan number and 𝑛 is the total number of A-scans. Coordinate location 
of each point on an A-scan was calculated by 
𝑥𝑖 = 𝑑𝑖 cos 𝜃𝑖 ,  𝑦𝑖 = 𝑑𝑖 sin 𝜃𝑖 (2.5) 
where 𝑥𝑖 and 𝑦𝑖  are the coordinate locations in Cartesian coordinate and 𝜃𝑖 and 𝑑𝑖  are the 
angle and distance in polar coordinate. Points not obtained through conversion are 
interpolated by averaging the neighboring points.    
 
Figure 2.6: a) Polar IVOCT B-scan, b) Rectangular IVOCT image  
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APPLICATIONS OF IVOCT IN STENTING 
Angioplasty, in practice for over 40 years, offers a general look at the coronary 
arteries and can locate occlusion sites, however; the method is not capable of providing the 
detailed information required to assess the arterial walls in patients undergoing coronary 
stenting. One of the causes of stent restenosis is poor stent apposition; that is when the stent 
has not been expanded fully within the artery. Physicians, concerned with injuring the 
artery with balloon inflation, can end up under-inflating the balloon and stent. Accurate 
measurements of the diameter of the arterial lumen assist the selection and sizing of stents 
and balloons [14]. Once the stent has been deployed, further assessment is required to 
examine the stent struts in relation to the arterial wall and plaque. If the stent has been 
undersized, a larger balloon can be directed to it and expanded to fit the stent optimally. 
Furthermore, post deployment follow-ups are required to examine the degree of restenosis 
within a few months after the procedure [14]. 
Intravascular Ultrasound (IVUS) have been incorporated into catheterization labs 
to assist with coronary stenting [15-18]. IVUS uses echocardiography: ultrasonic waves of 
20-50 MHz frequencies are emitted by a transducer and reflect from the various tissue 
structures and the echo of these waves is converted into an image. The transducers are 
placed on the tip of a catheter which is slipped into the coronary arteries over the same 
guide wire that is used to deploy the stents and provides a cross-sectional view of the artery. 
IVUS provide images with resolution of 80-120 m and penetration depth of 4-7 mm. 
IVOCT provides images of coronary arteries with axial resolution of 10-20 μm and 
tissue penetration depth of 1.5-2.0 mm. Although IVOCT does not penetrate tissue as deep 
as intravascular ultrasound (IVUS), finer image resolution of one order-of-magnitude 
allows IVOCT to provide information that IVUS cannot offer and therefore gives this 
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imaging modality important advantages as an assessment technique for coronary stenting 
[19-24]. 
Figure 2.7-a and b illustrate IVUS and IVOCT images of a coronary stent at the 
same site. Stent struts’ positions and orientations relative to the vessel wall are more 
distinct on the image acquired by IVOCT compared to IVUS, making it easier to identify 
underdeployed stents. Figure 2.7-c and d compare IVUS and IVOCT images of neoitimal 
layer covering a Sirolimus-eluting stent at the same cross section. Where IVUS cannot 
detect neointimal layers in the majority of Sirolimus-eluting stents at the chronic phase, 
IVOCT is able to detect thinner neointima. 
 
Figure 2.7: Stent image of Right coronary artery (RCA) obtained by a) IVUS, b) IVOCT 
[25], cross-sectional images of SES at 6-month follow-up obtained by c) 
IVUS and d) IVOCT [26] 
IVOCT IMAGING ARTIFACTS 
There are several artifacts associated with the images produced by IVOCT systems 
some of which are common to both IVOCT and IVUS. These artifacts were first stated by 
Bezerra et al [26].  
 Residual blood: results in attenuation and scattering of the IVOCT light beam, 
leading to a poor image quality (Figure 2.8-a).    
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 Saturation artifact: occurs when amplitudes of the reflected light from a highly 
reflective surface (stent struts) exceeds the dynamic range of the data acquisition 
system and gives rise to “streamers” (Figure 2.8-b).  
 Sew-up: artifact is a single point misalignment of the lumen border, resulting from 
rapid artery or imaging wire movement between successive B-scan in the pullback 
(Figure 2.8-c). 
 Bubble artifact: occurs when small gas bubbles are formed in the silicon lubricant 
used to reduce friction between the sheath and the revolving optic fiber in OCT 
systems. It can attenuate the signal along a region of the vessel wall, and images 
with this artifact are not suitable for tissue characterization (Figure 2.8-d). 
 Nonuniform rotational distortion (NURD) is the variation in the rotational speed of 
the catheter which results in the distortion of the image. 
 
Figure 2.8: IVOCT imaging artifacts a) residual blood artifact, b) saturation artifact, c) 
sew-up artifact, d) bubble artifact [26] 
 Sunflower artifact: refers to the ‘bending’ of the stent struts towards the catheter - 
analogous to a sunflower bending toward the sun. Sunflower effect occurs when 
the catheter is at eccentric positions in the vessel lumen and is most pronounced 
when the catheter is adjacent to the luminal wall. The metal struts appear as a 
straight line, perpendicular to the imaging light beam and may be obliquely oriented 
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to the luminal wall which makes well-opposed stent struts appear poorly opposed 
(Figure 2.9-a).  
 Merry-go-round effect: referred to the elongation of the stent strut which is due to 
the combination of an eccentric catheter position and scattering of the light beam 
caused by residual blood (Figure 2.9-b).  
 
Figure 2.9: a) sunflower artifact, b) merry-go-round artifact 
Among the aforementioned artifacts, the sunflower and merry-go-round effects 
have a great impact in assessment of coronary stents. Due to the tortuosity of the arteries, 
the catheter is often adjacent to the vessel wall during a pullback which inevitability results 
in these artifacts. Considering the significance of the misinterpretation of IVOCT images, 
development of a correction scheme is necessary. This can be achieved by first 
understanding the mechanism of the artifacts and successfully reproducing them. 
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Chapter 3: Models for studying IVOCT artifacts  
To characterize IVOCT imaging artifacts two models were created; a physical 
blood vessel model to acquire images under controlled conditions and a computer model 
using physical and physiological based parameters to perform optical simulations.      
PHYSICAL BLOOD VESSEL MODEL 
Phantom blood vessels were constructed with elastic and optical properties 
comparable to arterial walls. Coronary stents were deployed within phantom vessels and 
were imaged by Micro-CT as a reference. IVOCT images of phantom vessels with 
deployed stents were acquired to examine artifacts.   
Phantom vessel material 
The base material was polydimethylsiloxane (PDMS) which is available as an 
unpolymerized liquid resin with a separate curing agent. PDMS is optically clear with 
refractive index (𝑛𝑑) of 1.40 [27], slightly higher than that of tissue (𝑛𝑑 = 1.34). Titanium 
dioxide (TiO2) is a highly effective scatterer that is available as a white powder with 
different particle sizes. Depending on the desired scattering coefficient (𝜇𝑠), a specified 
amount of TiO2 was added to the liquid PDMS and mixed with the curing agent which 
resulted in the material setting to form a stable solid. 
Scattering coefficient measurement  
To determine the required amount of TiO2 to obtain desired scattering coefficients, 
a mix of PDMS and TiO2 at specific concentration was spread on glass slides, forming thin 
layers of controlled thicknesses. After allowing samples to cure for 24 hours, transmitted 
light through the samples was measured by a spectrometer. Since PDMS absorption in 
near-infrared range is negligible [28], total loss is considered the result of scattering by 
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TiO2 particles. The relationship between transmitted light fraction and the scattering 
coefficient is given by  
𝑇(𝑧) = 𝑒−𝜇𝑠𝑧  (3.1) 
where 𝑇 is the transmitted light fraction, 𝑧 (mm) is the distance light travelled (film 
thickness) and 𝜇𝑠 (mm
-1) is the scattering coefficient. By replacing the measured values of 
𝑇 for known 𝑧 thicknesses, 𝜇𝑠  was calculated and averaged. The relationship between 
scattering coefficient and concentration is given by  
𝜇𝑠 = 𝜌 𝜎𝑠  (3.2) 
where 𝜇𝑠 (mm
-1) is the scattering coefficient, ρ (mm-3) is the number concentration and  𝜎𝑠 
(mm2) is the scattering cross section. Having found 𝜇𝑠  corresponding to TiO2 concentration 
used in the measurements and considering their linear relationship, required concentrations 
for different 𝜇𝑠 values can be determined. Scattering strength of biological tissues are 
reported by measuring reduced scattering coefficient (𝜇𝑠′) which is related to 𝜇𝑠 by 
𝜇𝑠′ = (1 − 𝑔) 𝜇𝑠  (3.3) 
where 𝑔 is anisotropy factor which represents the average direction of scattered light (𝑔 =
〈cos 𝜃〉). PDMS demonstrates isotropic scattering (𝑔 = 0.5) [29] whereas biological tissues 
are highly forward scattering with 𝑔 ≈ 0.8-0.9 [30]. 
Blood vessel phantom fabrication  
A mold for the phantom vessel was constructed of aluminum and brass as illustrated 
in Figure 3.1. The cylindrical aluminum housing has two parts that fixed the outer diameter 
of phantom vessels at 6mm and length of phantom vessels at 25 mm (Figure 3.1-a). 
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Aluminum halves fit together with two steel pins (Figure 3.1-b) and cylindrical brass post 
inserts into an aluminum base to form mold for inner vessel lumen (Figure 3.1-c). Two 
brass cylinders with diameters of 3 mm and 4 mm were fabricated to give lumen diameters 
of 3 and 4 mm. Aluminum base plate fastened to joined-aluminum halves with two steel 
screws (Figure 3.1-d). 
 
Figure 3.1: Mold to construct phantom blood vessels, a) cylindrical aluminum housing, 
b) steel pins fit halves together, c) cylindrical brass post, d) aluminum base 
plate fastened to joined-aluminum halves. 
Phantom mix was prepared with PDMS and a curing agent. PDMS and curing agent 
were mixed in ratio of PDMS to curing agent of 10:1. Titanium dioxide (5 mg/ml) was 
added to the PDMS-curing agent mix at 5 g TiO2 per 1 liter PDMS/curing agent mix.  The 
mix was poured into the mold and placed in a vacuum chamber at -25 psi gauge pressure 
for approximately 30 minutes to remove bubbles, and allowed to cure for 24 hours. The 
two aluminum halves were taken apart from the sides, leaving the phantom on the base 
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with the brass cylinder in the middle. The phantom was pulled along the axis of the brass 
cylinder until it was completely removed (Figure 3.2-a).  
Stent deployment within phantom vessels 
Metallic drug-eluting stents that were utilized in this study include 3.0×8mm 
CYPHER® Sirolimus-eluting stent (Cordis), 3.0×9 mm Endeavor® Zotalorimus-eluting 
stent (Medtronic), 3.0×8 mm TAXUS® Liberte® Paclitaxel-eluting stent (Boston 
Scientific), 3.5×8 mm TAXUSTM Express2TM Paclitaxel-eluting stent (Boston Scientific), 
4.0×12 mm XIENCE V Everolimus-eluting (Abbott Vacular). In addition, one 
bioabsorbable stent, a 3.0×18 Absorb™ stent (Abbott Vascular) was also used. Each Stent 
which is mounted on a balloon was inserted in a phantom vessel and the balloon was 
inflated at pressure of 16 atm for 30 seconds. Expanded stent stayed inside the phantom 
while the balloon was deflated and removed (Figure 3.2-b). The bioabsorable stent was 
deployed within the phantom vessel that was submerged in a water bath at 37 °C body 
temperature to prevent any structural damage to the polymer.   
 
Figure 3.2: a) Constructed opaque phantom vessel, b) phantom vessel with deployed 
stent.  
Micro-CT imaging  
Micro-CT imaging of stents deployed in the phantom vessel were acquired and 
utilized as a “gold standard” image reference of stent struts’ dimensions, position and 
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orientation relative to the phantom vessel wall.  Stents were scanned at the High-Resolution 
X-ray CT (HRXCT) Facility at The University of Texas at Austin. A FeinFocus microfocal 
X-ray source operating at 200 kV and 0.17 mA with no X-ray prefilter was employed with 
an empty container wedge. Micro-CT slice thickness corresponded to one line in a CCD 
image intensifier imaging system, with a source-to-object distance of 19 mm. For each 
slice, 1000 views were recorded with two samples per view. Field size of image 
reconstruction was 6mm, pixel grayscale was adjusted with an offset of 4000 and scale of 
300. Each dataset consisted of 1750-2375 slices (depending on the length of the stent) 
recorded along the long axis of the stent. Each image slice was rendered at 1024×1024 
pixel resolution, resulting in an in-plane resolution of 5.86 µm per pixel. Image slices were 
contiguous each with a thickness of 6.62 µm (Figure 3.3).  
 
Figure 3.3: Micro-CT images of a CYPHER® stent a) three-dimensional reconstruction 
of a longitudinal portion of a stent, b) a cross sectional view of the phantom 
vessel with pixel size of 5.86µm.  
Higher resolution Micro-CT imaging of a stent strut was completed to simulate 
light interaction between an IVOCT catheter and stent strut. For this work, high resolution 
close-up scans of a CYPHER® and an Endeavor® struts were acquired using an Xradia 
microXCT scanner operating at 150 kV and 10 W with no X-ray prefilter employing a 40X 
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detector. A total of 369 views were acquired over an angular extent of ±92°, integration 
time for each view was 20 seconds. The object-to-detector distance was set at 9.2 mm while 
the object-to-source was at 37.5 mm, resulting in 0.53 micron resolution (both in-plane and 
interslice). To remove instrumentation artifacts from the reconstruction, a reference image 
consisting of 45 averaged frames was subtracted from each recorded frame. The resulting 
dataset consisted of 944 slices each with 788×1024 pixels. A three-dimensional 
representation of the strut was stored in a stereolithography (STL) file format. 
 
Figure 3.4: a) selected strut of a CYPHER® stent, b) cross sectional view of the strut, c) 
three dimensional STL of the stent strut.  
IVOCT imaging setup 
An apparatus was designed to fix position of the phantom vessel while acquiring 
IVOCT images in presence of a flush fluid (Figure 3.5). The phantom vessel with deployed 
stent was placed inside a container which was mechanically fastened to two translation 
stages and two goniometers to adjust position and orientation of the phantom vessel. The 
catheter attached to a guide wire was passed through the phantom vessel and fixed at both 
ends and flush fluid was injected with a syringe. Pure saline and mix of saline and goat 
blood were used as flush fluid for different experiments. Images were acquired using 
frequency domain IVOCT system (CoreVue, Volcano Corporation, Billerica, MA) 
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providing 20,000 A-scans per second and frame rate of 30 frame/sec. Before each 
recording, the tip of the fiber inside the 3.1 French catheter was moved to the region of 
interest and the length (10-20 mm) and velocity (1-2 mm/s) of the pullback, depending on 
length of the stent, were specified. 
 
Figure 3.5: IVOCT imaging setup: position and orientation of the phantom vessel (inside 
the container) was adjusted by translation stages and goniometers. Catheter 
attached to the guide wire was pulled back through the phantom vessel while 
flush fluid was injected with a syringe.  
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Reading IVOCT data in MATLAB 
IVOCT raw data are arranged as stacks of B-scans stored in a Datalog file format 
proprietary to National Instruments (Austin, TX). To access the A-scans, a LabVIEW file 
reader was written that opens the frames in a pullback one by one and appends each to the 
end of the binary file. After reading all frames in the pullback, all data is stored in a one-
dimensional array containing all A-scans of all frames. This binary file is then opened by 
a MATLAB reader which allows the user to access a specific A-scan by providing B-scan 
and A-scan reference numbers using the heather file.  
Contrast Group Refractive Index Measurement  
Group refractive index of a contrast agent (Omnipaque, GE Healthcare, 
Princeton, NJ) at wavelength of 1310 nm was measured using an OCT system [31]. This 
method was first introduced by Sorin et al. [32] to measure simultaneously group refractive 
index and thickness and has been applied in refractive index measurement of different 
tissues [33] and collagen films [34]. For this measurement, a glass capillary with 
rectangular cross section (4 mm  0.7 mm) was used to hold the contrast. First, the glass 
capillary without contrast was positioned under the optical fiber in the sample path of the 
measuring interferometer [31] and positions of reflections from the various glass-air 
interfaces recorded. Next, while maintaining the glass capillary in a fixed position, 
Omnipaque (350 mgI/ml) was injected into the lumen of the glass capillary to ensure 
OPL measurements of filled and un-filled capillaries were recorded at the same position.  
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Figure 3.6: a) cross sectional view of the glass tube and the optical fiber, 1-4 indicate the 
interfaces that reflect the light back into the fiber, b) S1-4 reflected signals 
from empty tube, S1’-4’ reflected signals when the tube is filled with contrast.  
Optical pathlengths of the air-filled (𝑑𝑎𝑖𝑟) and contrast-filled (𝑑𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡) glass 
capillary lumen are measured by the difference between S3 and S2 and the difference 
between S3’ and S2’, respectively. Group refractive index of contrast (𝑛𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡) was 
obtained as the ratio of 𝑑𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 to 𝑑𝑎𝑖𝑟, (𝑛𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 = 𝑑𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 𝑑𝑎𝑖𝑟⁄ ). The measurements 
were done three times and the average group refractive index of contrast was 1.455. 
COMPUTER MODEL 
Catheter/strut model  
Simulation of light transmission in a 3.1 French IVOCT catheter was achieved 
using optical design software (Zemax, Radiant, Redmond, WA). The catheter model 
(Figure 3.7) includes: a point source with cone angle of 6.315° and wavelength of 1310 
nm, a single-mode optical fiber (SMF-28 which features low-dispersion at 1310 nm) with 
mode field diameter of 10 m [35], a GRIN lens (0.5 mm diameter, 1.32 mm length and 
peak refractive index of 1.629), 0.150 mm glass (BK7) 45° prism and a polymer sheath 
(𝑟𝑜-𝑟𝑖  = 152 m). In optical simulations, the space (256 m) between glass prism and sheath 
is filled with contrast. Simulation of light propagation through the catheter and vessel 
lumen was completed in a non-sequential ray tracing mode. The light beam initiated at the 
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source (tip of optical fiber), transmits and is focused by a GRIN lens, enters the prism and 
is reflected and passes through the sheath and leaves the catheter into the vessel lumen. 
Lumen space between the outer catheter sheath and stent strut is filled with contrast.  
 
Figure 3.7: Geometry of IVOCT catheter model and stent strut  
To simulate the reflection and scattering of light from a stent strut, the stereolithography 
(STL) object file obtained from Micro-CT imaging was imported into the IVOCT catheter 
model (Figure 3.7). Arterial tissue was added adjacent to the strut and bulk scattering inside 
the tissue was modeled using 𝜇𝑠 = 20 mm
-1 and Henyey-Greenstein phase function [36] 
which is widely used for the analysis of optical measurements on tissue where 𝑔 = 0.8. To 
include roughness of the contrast-vessel interface, Lambertian surface scattering was 
assumed. Flush fluid in the lumen is weakly scattering with a scattering coefficient of 𝜇𝑠  = 
0.2 mm-1, corresponding to a residual 0.1% blood concentration [37]. Specular reflection 
was assumed for the strut and light backscattered from the strut was collected into a 10 m 
diameter pupil and coupled back into the OCT catheter.  
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Beam spot-size variation 
Propagation of light beam through the space is described by a Gaussian profile. 
This variation of spot-size with distance from the catheter may affect the recorded IVOCT 
images when the catheter is at eccentric positions. Moreover, the catheter sheath introduces 
astigmatism aberration which results in the beam focusing differently along the axes. The 
variation of beam spot-size as a function of distance from the catheter was measured along 
different axes as illustrated in Figure 3.8, however, Zemax provide geometrical beam-spot 
size which reaches zero at focus.  
 
Figure 3.8: Beam profile and spot-size which focuses differently along axes due to 
astigmatism introduced by catheter sheath, close up: spot diagram at focus 
reaches 0.   
Since the imaging system is diffraction limited, the effect of diffraction on the spot-
size was accounted for by obtaining encircled energy plots (Figure 3.9-a). Radius of 10 m 
from the center corresponded to 80% of energy which was added to the beam spot-size to 
include effect of diffraction. The variation of beam spot-size with distance from catheter is 
demonstrated in Figure 3.9-b. The beam spot-size along x-axis focuses at a distance of 1.5 
mm form the catheter whereas it remains almost constant along y-axis.  
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Figure 3.9: a) Diffraction encircled energy, b) variation of beam spot-size with distance 
from the catheter along x- and y-axes.  
Simulation parameters 
Rotation of the IVOCT catheter was simulated in a 3mm diameter vessel lumen. 
Fiber in the IVOCT catheter was rotated over the strut with an angular range of 20 degrees 
in 0.5 degree steps and 200,000 rays were traced at each angular position. 
To examine the effect of beam size, distance between the catheter and strut was 
varied along the diameter of the vessel perpendicular to the flat side of the strut, 
corresponding to catheter offsets from the vessel center of 𝑟𝑐 = -0.50, 0.0, 0.50 and 1.00 
mm (Figure 3.10-a). To examine the effect of catheter eccentricity, catheter was shifted 
from the vessel center along the diameter parallel to the flat side of the strut, at catheter 
offsets from the vessel center of 𝑟𝑐 = 0.0, 0.30, 0.60 and 0.95 mm, changing the location of 
incident beam on the strut (Figure 3.10-b). To examine the effect of neointimal layer, 
simulation was completed for two cases with thicknesses of 50 and 400 m covering the 
stent strut while the catheter was centered (Figure 3.10-c). 
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Figure 3.10: Stent strut orientation with respect to IVOCT catheter: a) catheter positions 
along the diameter of the vessel perpendicular to the flat side of the strut, 𝑟𝑐 = 
0.50 (P1), 0.00 (P2), 0.50 (P3) and 1.00 mm (P4), b) catheter positions along a 
diameter parallel to the flat side of the strut, 𝑟𝑐 = 0 (P5), 0.30 (P6), 0.60 (P7) 
and 0.95 mm (P8), c) neoinitmal layers of 50 and 400 m. 
Non-sequential ray tracing  
At each catheter rotation, as the rays were traced, the ray data was saved to a file 
specified with a ZRD extension. The Ray Database Viewer reads in a ZRD file, and displays 
the data in a text format (Figure 3.11).  
 
 
Figure 3.11: Typical ray listing from reading a ZRD file. 
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Seg# is the segment number, the part of the ray that travels through a particular 
medium, Prnt is the parent number, prior segment that generated the particular segment, 
Levl is how many segments away from the source ray the segment is, In indicates what 
object number the segment is traveling through, Hit indicates the object number struck at 
the end of the segment, XRTS DGEF BZ is a quick indicator of what happened to the 
segment. X means terminated, R reflected, T transmitted, S scattered, D diffracted, and B 
bulk scattered. All these values indicate what happened at the end of the segment. The 
values G, E, and F indicate whether the segment was a ghost, diffracted, or scattered, 
respectively, from the parent segment, so these events occurred at the start of the segment. 
The symbol Z indicates a ray error occurred and the ray was terminated. The other data 
displayed includes the global XYZ coordinates of the end of the segment, the global normal 
vector coordinates of the object struck at the end of the segment, the ray intensity and the 
object comments. To display only the rays with certain properties, Filter Strings were used 
which allow definition of a conditions that rays must pass before they are displayed. Filter 
String syntax indicates if one segment within a ray hit, miss, reflected, refracted, scattered, 
diffracted, or ghost reflected from an object [38].  
In this simulation, the rays that were reflected after hitting the stent strut and 
travelled back to the tip of the fiber were saved in a ZRD file. Parameters that were saved 
in a text file included coordinate locations on the stent strut of returned rays; intensity and 
direction-of-cosines of the rays returning to the fiber tip and optical pathlength (OPL) of 
light returning to the catheter. 
To simulate rotation of the catheter, position and orientation of strut with respect to 
catheter were changed for each angular step. To achieve this automatically, Zemax 
Programming Language (ZPL) was used. ZPL is a macro language specifically designed 
for use with Zemax which allows the user to write a particular calculation or graphical 
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display which is not built in. A ZPL macro consists of a series of commands similar to 
other programming languages, as well as capabilities and functions unique to ray tracing. 
Figure 3.12 shows an example of a macro used in this study, where for each angular step 
relative position and orientation of catheter and strut were varied and non-sequential ray 
trace is completed while Filter Strings are applied to collect desired rays and ray database 
is stored in ZRD file.   
 
Figure 3.12: Example of a ZPL macro to simulate catheter rotation   
Data analysis in MATLAB  
After opening each ZRD file in Ray Database Viewer, ray data was written to a text 
file. A reader was used to open and import the ray data to MATLAB R2013a (Mathworks, 
Natick, Massachusetts) for further analysis. Ray presentation as employed in Zemax 
describes the propagation of light and does not take into account the behavior of wave 
fronts. The amplitude of light coupled into a single-mode optical fiber is given by  
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𝐴𝑐 = ∫ 𝐴𝑜(𝑟) 𝐴𝑓
∗ (𝑟) 𝑑𝐴
+∞
−∞
  (3.4) 
where 𝐴𝑜(𝑟) is the incident beam and 𝐴𝑓
∗ (𝑟) is the fiber coupling function [39]. Coupling 
coefficient is defined by integrating the product of phase variation of incident rays (plane 
waves) and fiber coupling function (Eq.3.5) which characterizes dependence of coupling 
on the angle of incident beam: 
𝑐𝑓 = ∫ 𝛷𝑜(𝑟) 𝐴𝑓
∗ (𝑟) 𝑑𝐴 
+∞
−∞
  (3.5) 
where 𝛷𝑜(𝑟) is the phase variation of the incident ray (plane wave) and 𝐴𝑓
∗ (𝑟) is the fiber 
coupling function [13]. Eq.3.5 was solved using Wolfram Mathematica® 9 to find coupling 
coefficient:  
𝑐𝑓 = 𝑒
2𝜋𝜎2(𝑐𝑜𝑠 𝜃𝑥
2+𝑐𝑜𝑠 𝜃𝑦
2)/1.32 (3.6) 
where 𝜎 is the mode-field diameter of the optical fiber, 𝑐𝑜𝑠 𝜃𝑥 and 𝑐𝑜𝑠 𝜃𝑦 are direction of 
cosines of the incident beam along x and y axes. 
Product of coupling coefficient squared and recorded intensity of each ray gives the 
intensity of coupled light into the optical fiber. The resulting intensities were then 
convolved with longitudinal point-spread function corresponding to a full-width half 
maximum Gaussian spectral width of 50 nm. Data was presented in logarithmic scale 
(dBm) vs. depth in microns. A polar-to-cartesian conversion was performed on the A-scans 
to obtain simulated IVOCT images. 
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Chapter 4: IVOCT measurement of size and apposition of metallic 
stents 
Metallic stent struts typically appear as small bright line-segments in IVOCT 
images due to light reflection from the metal surface and are inconsistent with the true stent 
strut surface profile. Vessel curvature and tortuosity frequently result in placement of the 
IVOCT catheter in an eccentric position in the lumen, giving rise to stent artifacts including 
the sunflower and merry-go-round effects [26]. For instance, the size of a strut can appear 
smaller in IVOCT images acquired from an offset (Figure 4.1-b) compared with a centered 
(Figure 4.1-a) catheter position. In this chapter, effect of beam size and catheter position 
on the apparent size and apposition of metallic stent struts in IVOCT images were 
examined. 
 
Figure 4.1: Apparent strut size in a phantom: a) centered catheter, b) eccentric catheter 
where strut size varied (both arrows) and sunflower artifact is observed (large 
arrow) 
EFFECT OF SPOT-SIZE 
Variation in apparent strut size in IVOCT images due to beam-size change was 
examined by positioning the catheter at different distances from the strut in the Zemax 
computer model. When shifting the catheter from positions P1 to P4 (Figure 3.10-a), as the 
distance between the catheter and the strut increases, the measured size of the strut in the 
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IVOCT image varies non-uniformly; from 135 m (P1), 100 m (P2), 150 m (P3) and 225 
m (P4) as shown in Figure 4.2. Considering the actual size of the strut is 90 m, the effect 
of beam size introduces 60% error at 𝑟𝑐 = -0.5 mm, 11% error at 𝑟𝑐 = 0 mm, 67% error at 
𝑟𝑐 = 0.5 mm and 189% error at 𝑟𝑐 = 0.5 mm. At increased distances from the beam focus, 
IVOCT signal amplitude decreases and apparent strut blooming (along the light 
propagation direction) appears less. 
 
Figure 4.2: Simulated IVOCT images of a CYPHER® stent strut at selected offsets: a) P1 
(𝑟𝑐  = -0.5 mm), b) P2 (𝑟𝑐 = 0 mm), c) P3 (𝑟𝑐 = 0.5 mm), d) P4 (𝑟𝑐 = 1 mm). 
EFFECT OF STENT SURFACE-SCATTERING PROPERTIES 
Intensity of the reflected light back to the IVOCT catheter is partially dependent on 
the surface-scattering properties of the stent. A Gaussian surface-scattering model (bi-
directional scattering distribution function) was assumed for the strut. The expression is 
given by 
𝐵𝑆𝐷𝐹(𝑐𝑜𝑠 𝜃) = 𝐴 𝑒
−| 𝑐𝑜𝑠 𝜃|2
𝜎2   (4.1) 
where 𝐴 is a normalizing constant, angle 𝜃 is measured from the normal and the 
dimensionless value𝜎 determines the width of the Gaussian distribution. The resulting 
distribution is rotationally symmetric in direction of cosines space, no matter what angle 
the specular ray makes with respect to the surface normal [38]. Standard deviation of the 
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direction of cosines of 𝜎 = 0.05, 0.25 and 0.5 was assumed where increasing values of 𝜎 
corresponds to rougher strut surfaces with higher scattering. Reflectivity was measured as 
the number of returned rays divided by the total number of incident rays.  
Reflectivity vs. catheter beam angle for increasing values of 𝜎 are shown in Figure 
4.3. Stents with less surface scattering have higher reflectivity with the maximum peak of 
0.77% corresponding to 𝜎 = 0.05 and consequently, appear brighter in the recorded IVOCT 
images.  
 
Figure 4.3: Reflectivity vs. catheter beam angle for different bi-directional scattering 
distribution functions (see Eq. 1.3): a) 𝜎 = 0.05, b) 𝜎= 0.25, c) 𝜎= 0.50. 
The angular spread of reflected light coupled back into the IVOCT catheter 
becomes broader as  increases, increasing from 2.3° to 3.4° of catheter rotation (Table 
4.1). Therefore, stents with a broader BDSF surface scattering (larger result in the 
appearance of wider stent struts in IVOCT images. 
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𝝈 ∆𝜶(°) 𝑹𝒎𝒂𝒙(%) 
0.05 2.3 0.77 
0.25 2.8 0.63 
0.50 3.4 0.2 
Table 4.1: Standard deviation of the direction of cosines (𝜎) for different stent surface-
scattering; beam angular spread (∆𝛼) of reflected light returned to the catheter 
and reflectivity (𝑅𝑚𝑎𝑥). 
Simulation results demonstrate that surface-scattering properties of stents impact 
the reflectivity and apparent size of the strut in IVOCT images. The result also suggests 
that modifying the surface scattering features of stent struts is a candidate approach of 
controlling IVOCT imaging artifacts.  
EFFECT OF POLAR TO RECTANGULAR TO TRANSFORM 
The conversion from polar B-scans to rectangular IVOCT images can introduce an 
anisotropic shape transformation. Magnitude of the anisotropy is dependent on a number 
of factors including: 1) number of A-scans in a B-scan; 2) number of axial points in an A-
scan; and 3) pixel format of the polar IVOCT image; and 4) distance from the catheter 
center. Polar B-scan data (Figure 4.4-b) corresponding to the image acquired at an eccentric 
catheter position contains more pixels in the radial direction (horizontal) and fewer pixels 
in the angular direction (vertical) compared to the corresponding rectangular IVOCT 
image. In the coordinate transformation, features in the polar B-scan image appear 
compressed axially and stretched azimuthally in the rectangular IVOCT image. In case of 
a specified strut (Figure 4.4, black circle) the circular-shaped strut in the polar B-scan data 
(Figure 4.4-b) transforms to an ellipse with anisotropy of 3.5 in the rectangular IVOCT 
image (Figure 4.4-a). Since radial scale is constant, the aspect ratio of the strut in IVOCT 
image depends on the angular scale which is directly proportional to the distance of the 
strut from the catheter center. Because this anisotropy may be greater than 1, the coordinate 
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transformation from polar B-scan data to rectangular IVOCT images is a factor 
contributing to the sunflower effect. 
 
Figure 4.4: a) IVOCT image of phantom vessel with eccentric catheter, black circle 
marks position of one strut, b) corresponding polar B-scan data 
SUNFLOWER EFFECT IN IVOCT IMAGES OF PHANTOM VESSELS 
To observe the sunflower effect and dependence on catheter eccentricity, IVOCT 
images of the phantom vessel with deployed stents were recorded. At a fixed longitudinal 
position the catheter was first positioned at the center of the phantom vessel lumen; while 
translating towards the vessel wall IVOCT images were recorded. Figure 4.5 illustrates 
sunflower effect; while all stent struts appear well-opposed to the vessel wall when the 
catheter is centered, at an eccentric catheter position some struts appear in the recorded 
IVOCT image as a straight line perpendicular to the light beam and obliquely oriented to 
the luminal wall. The apparent struts lifting off the vessel wall may result in some IVOCT 
users erroneously concluding the stent is malopposed. 
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Figure 4.5: a) IVOCT image of phantom vessel with centered catheter, b) IVOCT image 
of phantom vessel with eccentric catheter; Note some stent struts “bend” 
toward the light demonstrating sunflower effect 
SIMULATION OF SUNFLOWER EFFECT  
Size of the strut region reflecting light into a contrast-filled 3.1 French catheter at 
the four catheter eccentric positions (P5-P8) was computed (Figure 3.10-b). Results suggest 
that lateral size of the strut region reflecting light back into the IVOCT catheter can be 
smaller than the incident beam size. Figure 4.6 illustrates the stent strut orientation with 
respect to catheter at four different eccentric positions and the incident beam size (red) and 
the regions reflecting light back into the catheter (yellow) at each position. At each of the 
catheter offsets considered, optical pathlength (OPL) of light returning to the catheter over 
the beam angular spread is nearly constant with a maximum standard deviation of 15 μm. 
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Figure 4.6: Stent strut orientation with respect to IVOCT catheter, incident beam (red) 
and regions on strut reflecting light back into the catheter (yellow) at: b) P5 
(𝑟𝑐 = 0 mm), c) P6 (𝑟𝑐 = 0.3 mm), d) P7 (𝑟𝑐 = 0.6 mm), e) P8 (𝑟𝑐 = 0.95 mm). 
ORIGIN OF SUNFLOWER EFFECT  
The sunflower effect is an IVOCT artifact observed when imaging metal coronary 
stents deployed in patients during cardiac catheterization and appears as a bending of stent 
struts toward the imaging catheter - analogous to a sunflower bending toward the sun. 
Sunflower effect occurs when the catheter is at eccentric positions in the vessel lumen and 
is most pronounced when the catheter is adjacent to the luminal wall. When an eccentric 
IVOCT catheter emits light that is incident on a metal stent strut at any angle, returning 
light to the catheter is reflected from a small-sized region on the metal strut surface (Figure 
4.7, black arrow), while other strut surface areas reflect and scatter light away from the 
catheter (Figure 4.7, gray arrows). As light transmits from the catheter, a finite beam width 
at the stent strut ensures return reflections are recorded at each angular position. Since 
reflections return from a small-sized region on the stent strut, echo-time is nearly constant 
at each angular position and the metal strut appears in IVOCT images as a straight line 
bending towards the catheter (Figure 4.7, dotted blue line). Therefore, the sunflower effect 
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can artifactually make stent struts appear poorly opposed when in fact they are well 
opposed to the luminal wall. 
 
Figure 4.7: An eccentric IVOCT catheter emits light that is incident on metal stent struts 
at two angular positions. 
Complete deployment of coronary stents improves long term patient outcomes, and 
an early application of IVOCT is to verify full deployment. Although IVOCT provides 
high resolution images of stent struts to make this assessment, the sunflower effect can 
erroneously lead to a conclusion of stent under-deployment. Since one does not know - a 
priori - where on the strut light is reflecting back into the catheter, a fundamental 
uncertainty is recognized when selecting the point on the apparent strut to measure distance 
to the vessel wall. Moreover, this uncertainty cannot be resolved without knowledge of the 
location on the strut that is reflecting light back into the catheter. 
MALAPPOSITION MEASUREMENT  
Inasmuch as IVOCT stent measurements are at an early stage, no comprehensive 
consensus methodology exists on how to measure stent malapposition with off-center 
IVOCT catheter placement that is uniformly agreed upon [40]. In current IVOCT clinical 
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practice, two approaches are utilized to measure stent malapposition: approach 1) the user 
draws a line-segment from center of the strut blooming in the IVOCT image to the luminal 
wall that indicates the shortest distance (Figure 4.8-a), malapposition is determined by 
subtracting the known strut thickness from the measured distance [41], approach 2) a box 
representing the strut cross-section is positioned in the IVOCT image so that one box-edge 
is coincident with the leading edge of the IVOCT strut (blue box in Figure 4.8-b), the 
user/software draws a line segment from the midpoint of the opposing box-edge to luminal 
wall that is perpendicular to the box-edge, length of this line indicates strut malapposition 
[1]. 
 
Figure 4.8: Malapposition measurement: a) approach 1; yellow line is drawn from center 
of strut blooming to the luminal wall indicating the shortest distance, b) 
approach 2; box is positioned so that edge is coincident with the leading edge 
of the stent and green line is drawn perpendicular to the box-edge.   
Simulated IVOCT images of a CYPHER® stent strut that is 200 m under-deployed 
at catheter positions P5-P8 (Figure 3.10-b) are shown in Figure 4.9 where the apparent strut 
demonstrates the sunflower effect by appearing as a short line (white) directed 
perpendicular to the incident light beam and obliquely oriented to the luminal wall (Figure 
4.9-b to d). 
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Figure 4.9: Apposition measurements of a CYPHER® stent strut at selected offsets: a) P5 
(𝑟𝑐 = 0 mm) b) P6 (𝑟𝑐 = 0.3 mm) c) P7 (𝑟𝑐 = 0.6 mm) d) P8 (𝑟𝑐 = 0.95 mm), 
yellow line is drawn from center of strut blooming to the luminal wall 
indicating the shortest distance (approach 1), box is positioned so that edge is 
coincident with the leading edge of the stent and green line is drawn 
perpendicular to the box-edge (approach 2).   
Strut apposition was measured by the aforementioned two approaches. In approach 
1, a line was drawn from center of the strut blooming to the luminal wall (Figure 4.9; yellow 
lines), malapposition was determined by subtracting the known strut thickness (120 m) 
from the measured distances. Measurement errors varied from 4 m at 𝑟𝑐  = 0.0 mm to 1 
m, 4 m and 7 m at 𝑟𝑐  = 0.30 mm, 0.60 mm and 0.95 mm respectively (Figure 4.9-a to 
d). In approach 2, a 120 m thick box was placed along the apparent IVOCT strut and a 
line segment from the midpoint of the opposing box-edge to luminal wall that is 
perpendicular to the box-edge, indicating the mal-apposed distance (Figure 4.9; green 
lines). When the catheter is centered, the measured apposition is equivalent to the actual 
distance of the strut from the arterial wall. When the catheter is at eccentric positions, the 
measured appositions for the under-deployed strut produced artifactual errors of increased 
malapposition: 2 m at 𝑟𝑐 = 0.30 mm, 25 m at 𝑟𝑐  = 0.60 mm and 82 m at 𝑟𝑐  = 0.95 mm 
(Figure 4.9-b to d).  
The two approaches to measure stent apposition give different results for catheter 
positions P6-P8 (Figure 3.10-b). While approach 1 gives accurate apposition measurements 
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for positions P6-P8, approach 2 introduces artifactual errors. Apposition measurement 
errors introduced when applying approach 2 at positions P6-P8 originate from misplacement 
of the box representing the stent strut. In these cases, placement of the box so that one box-
edge is coincident with the leading edge of the IVOCT strut can introduce position and 
orientation errors. At positions P6-P8, light reflects from a small corner or edge region of 
the stent strut so that strut blooming in IVOCT images is not oriented parallel to the strut 
edge - thereby introducing the sunflower effect. Alternatively, when the box representing 
the stent strut is placed correctly (Figure 4.10-a) an accurate apposition measurement is 
obtained (Figure 4.10-b). In cases when the box is not utilized, approach 1 gives consistent 
measures of strut apposition and is equivalent to the method first described by Ughi et al. 
[42] in which the line segment is perpendicular to luminal wall. When utilization of the 
stent strut box is desired, the box should be positioned parallel to the arterial wall (Figure 
4.10-b) with the corner- or edge-region touching the center of the strut blooming in the 
IVOCT image. 
Observation of all stent struts in the IVOCT image can be used for better estimation 
of orientation and therefore proper placement of boxes. For example, a partially under-
deployed stent where the sunflower effect is observed is shown in Figure 4.10-c. To 
estimate malapposition, a circle is drawn tracing the circumference of the stent and boxes 
are placed facing the center of the stent. Malapposition is determined by measuring 
distances from the back surface of the boxes to the luminal wall. Applying approach 1, 
yellow lines are drawn from the center of strut blooming to the arterial wall perpendicular 
to the pink circle and the measured malapposition distances match the actual values. 
Approach 1 provides accurate results in presence of sunflower effect and does not require 
proper placement of the box representing the strut. 
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Figure 4.10:  a) Actual position of CYPHER® stent strut, b) proper box placement 
provides an accurate malapposition measurement at P8 (𝑟𝑐 = 0.95 mm), c) 
proper box placement based on distribution of all stent struts for accurate 
malapposition measurement by approach 2, yellow lines represent 
malapposition measurement by approach 1. 
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Chapter 5: IVOCT imaging of coronary artery metallic stents with 
neointimal coverage 
IMPORTANCE OF NEOINTIMA FORMATION 
Formation of neointima after stent deployment is an important indicator of vascular 
healing process. While presence of neointimal layers are desired in the healing response, if 
the neontimima thickens excessively re-stenosis results - a frequent complication with bare 
metal stents. To prevent re-stenosis, drug-eluting stents limit neointimal formation by 
releasing immunosuppressant pharmaceuticals which inhibit smooth muscle cell 
proliferation (Figure 5.1). In a recent study, CYPHER® and TAXUS® stents resulted in 
delayed neointimal formation when compared with bare metal stents of similar implant 
duration [43]. Human pathology studies suggest that the lack of neointimal strut coverage 
due to delayed vascular healing may be associated with late thrombotic events after stent 
deployment [44]. Therefore, accurate in vivo assessment of neointimal formation early 
after stenting may aid in prevention of late stent thrombosis. Although IVOCT offers a 
superior assessment technique, the clinical significance of a neointimal thickness that is 
less than or near the axial resolution of the IVOCT system is not well understood. In cases 
where struts may have partial tissue covering, some investigators consider the strut as 
covered, whereas others suggest that these struts be classified as having incomplete 
coverage [40]. A study on accuracy of IVOCT in analyzing the neointimal response to 
several drug-eluting stents, showed significant variation in the estimation of strut coverage 
between IVOCT and histology when the neointimal thickness was between 20 to 80 m 
[45] which is the range of thicknesses corresponding to thin neointimas formed early after 
stenting. Issues arising from tissue processing, shrinkage and artifacts associated with 
histology studies call for further investigations. 
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Figure 5.1: a) lack of neointima, b) desired neointimal coverage [46]  
PHANTOM NEOINTIMA FABRICATION 
An aluminum mold was built to add neointima coverage to the stent deployed inside 
the phantom vessel (Figure 5.2). The two pieces of the mold fasten together with a threaded 
cylinder where the mid-section has a 2.70 mm diameter, providing 150 micron space 
between phantom vessel wall and outer surface of the mold. Considering thickness of the 
stent struts, phantom layer covering the stent is 50 microns thick. The two ends have a 
larger diameter of 3.2 mm to hold the mold inside the phantom and the holes which open 
to the space between mold and vessel wall, allow injection and extrusion of phantom 
intimal material. Figure 5.2-b illustrates positioning of the mold inside a translucent 
phantom vessel. Outer surface of aluminum parts was coated with Teflon to prevent PDMS 
from sticking to the mold.   
 
Figure 5.2: Mold to add phantom neointima coverage over the deployed stent: a) two 
pieces of the aluminum mold fasten together to provide a space between 
phantom vessel wall and outer surface of the mold to inject neointima 
material, b) mold placed inside a translucent phantom vessel. 
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Two pieces of the mold were inserted into phantom vessel from the two ends and a 
mix of PDMS and titanium dioxide was injected into the space between aluminum cylinder 
and vessel wall (Figure 5.3). After curing for 24 hours, the two halves of the aluminum 
cylinder were removed, leaving a phantom neointima covering the deployed stent.  
 
Figure 5.3: Addition of phantom neointima to the deployed stent inside phantom vessel.  
ESTIMATING OPTICAL PROPERTIES OF NEOINTIMA 
Optical properties of neointimal tissue, required for construction of phantom 
neointimas and optical simulations, have not been measured. As an approximation, 
properties of tissues with similar structures and reported values were utilized. Pathological 
observations of coronary stenting in humans have been reported in a few studies. Anderson 
et al. [47] reported presence of stent endothelialization and a thin neointima containing 
smooth muscle cells after 21 days. Komatsu et al. [48] showed actinpositive intimal smooth 
muscle cells 30 days after stenting. Van Beusekom et al. [49] reported leukocytes, platelets, 
and fibrin at three days and complete endothelial stent coverage and a smooth muscle cell-
rich neointima after three months. Virmani et al. [50] published a comprehensive study on 
human coronary artery morphology early and late after stenting. Early after stenting (≤11 
days) fibrin, platelets, and acute inflammatory cells (neutrophils) were nearly always 
present in association with stent struts (Figure 5.4-a). A well-defined neointima containing 
smooth muscle cells in a proteoglycan-collagen matrix and chronic inflammatory cells 
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(lymphocytes and macrophages) were recognized beginning about 2 weeks after stenting 
(Figure 5.4-b). 
 
Figure 5.4: a) neonitimal formation after 3 days; fibrin, platelets, and acute inflammatory 
cells, b) neointimal formation after 120 days; smooth muscle cells, 
proteoglycan-collagen matrix, and chronic inflammatory cells [50]. 
Considering the cellular structure of neointimal layers, optical properties of human 
skin was selected where epidermis represents thin neonimas early after stenting and dermis 
represents thick neointimas in long term stenting. Reported scattering coefficients [51] and 
refractive indices [52] of epidermis and dermis at wavelength of 1310 nm are s = 12.7 cm-
1 with n = 1.42 and s = 8.1 cm-1 with n = 1.37, respectively.  
MICRO-CT IMAGES OF PHANTOM NEOINTIMA 
Micro-CT imaging of phantom vessels with neointimal coverage were acquired 
applying the protocol described in section 3.1.5. When imaging the thin neointima, higher 
power was used to achieve a resolution of 3.5 µm (Figure 5.5). 
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Figure 5.5: Micro-CT images of neointimal coverage over TAXUS® Liberte® stents; a) 
Micro-CT cross sectional image of thick neointima with resolution of 5.8 µm, 
b) Micro-CT cross sectional image of thin neointima with resolution of 3.5 
µm. (negative images included for more visibility of phantom neointima 
layers)  
IMAGE REGISTRATION 
Image registration between IVOCT and Micro-CT data sets was performed in 
MATLAB (Mathworks, R2013a). Due to lower resolution, a single IVOCT frame 
corresponded to 7 Micro-CT sequential images of thick neointima and 18 sequential 
images of thin neointima. Therefore IVOCT frames were compared to superposition of 
Micro-CT images and a 125 m diameter optical fiber oriented parallel to the long axis 
was embedded in the phantom vessel and used as marker. 
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Figure 5.6: Image registration: an IVOCT frame (top left) and corresponding Micro-CT 
image (top right) obtained from superposition of 7 sequential images (bottom)  
ACCURACY OF NEOINTIMAL THICKNESS MEASUREMENT  
Measurements of neonitimal thickness from IVOCT images were compared to 
values obtained from Micro-CT images which represent actual neointimal thickness. 
Examples of thickness measurement for thick and thin neointimas are given in Figure 5.7 
where we were able to measure the thickness of neointimal layers in IVOCT images as thin 
as 30 m accurately. IVOCT and Micro-CT measurements of thicker neointima (Figure 
5.7-a and b) match within 5 microns and in case of thin neointioma (Figure 5.7-c and d) 
there is a 2 microns error.  
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Figure 5.7: Neointimal thickness measurement; thick neointima by a) IVOCT and b) 
micro-CT and thin neointima by c) IVOCT and d) micro-CT. 
Thickness measurement was done for several IVOCT images and the 
corresponding micro-CT images. To obtain physical lengths, measured OPLs were divided 
by refractive index of PDMS (1.405), instead of average refractive index of 1.33 used in 
Corevue system software when the lumen is flushed with saline. In addition, a correction 
was applied for non-normal incident light direction which makes a 16° angle with normal 
in air. 
Measurements from 141 images of thick neointima are shown in Figure 5.8. Mean 
thickness measurement by IVOCT and micro-CT were 314.24 m and 305.38 m, 
respectively. Since micro-CT data is the gold standard, the fractional error in IVOCT 
measurements ([𝑚𝑒𝑎𝑛𝐼𝑉𝑂𝐶𝑇 − 𝑚𝑒𝑎𝑛𝑚𝑖𝑐𝑟𝑜−𝐶𝑇] 𝑚𝑒𝑎𝑛𝑚𝑖𝑐𝑟𝑜−𝐶𝑇⁄ ) was 0.03. Measurement 
errors arise from user placement of the line segment and uncertainty in image registration 
caused by a slight catheter tilt.  
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Figure 5.8: Measurement of thick neointima, red: IVOCT, blue: micro-CT.  
Thin neointima measurement was done from 25 IVOCT images, since in some 
cases phantom tissue did not form over the entire stent. Results are shown in Figure 5.9 
where mean thickness measurement by IVOCT and micro-CT were 48.47 m and 38.22 
m, respectively and the fractional error in IVOCT measurements was 0.27. User 
placement of line segment results in larger errors when measuring thin neointimas, 
nonetheless an error of 10 m is within the resolution of IVOCT.   
   
Figure 5.9: Measurement of thin neointima, red: IVOCT, blue: micro-CT.  
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EFFECTIVE LUMINAL SCATTERING 
Residual blood 
To study the effect of residual blood on detection of thin neointimal layers, goat 
blood was added to the saline at concentrations of 0.5, 1, 2 and 5%. IVOCT images of the 
stent with thin neointima coverage were acquired while the mix was injected by a syringe. 
As demonstrated in Figure 5.10 increasing the blood concentration increases luminal 
scattering, however, the presence of up to a 5% blood fraction does not affect the detection 
of thin neointimas. 
 
Figure 5.10: Effect of luminal scattering strength on detection of thin neointimas when 
flushed with: a) 0.5%, b) 1%, c) 2% and d) 5% blood volume fractions. 
Power injector study  
The scattering strength of flush fluid is unknown and measured with an OCT 
imaging system. A glass conduit with a rectangular cross section of 2×2 mm2 was used for 
this experiment (Figure 5.11). A Medrad® Mark7 ArterionTM injector (Bayer Healthcare) 
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was utilized to power-inject contrast through a catheter to the glass conduit while the OCT 
signal amplitude was monitored from the back luminal surface of the glass conduit. 
Contrast was flushed at flow rates of 4, 5 and 6 ml/s at maximum pressure of 300 psi for 3 
seconds while 300,000 A-scans were recorded at a fixed position. Measurement was 
repeated for glass conduit filled with contrast without flushing to obtain the background 
reference signal.  
 
Figure 5.11: Experimental setup to study scattering strength of flush fluid 
A-scans recorded during the middle second was used to ensure the beginning and 
end of flush did not affect the results. Signal intensity was averaged over every 100 A-
scans and subtracted by the back ground signal. Figure 5.12 demonstrates the recorded 
signal (dB) over 1 second for different flow rates. The variation in signal intensity is not 
significant and increasing the flow rate did not have a noticeable effect. Consequently, 
scattering caused by flushing the contrast is negligible and will not affect IVOCT images.  
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Figure 5.12: Intensity variation over 1sec for flow rates: a) 4 ml/sec, b) 5 ml/sec, and c) 6 
ml/sec. 
MERRY-GO-ROUND EFFECT DUE TO PRESENCE OF NEOINTIMA 
Thicker neointimas may result in merry-go-rounding of stent struts in IVOCT 
images. Figure 5.13-c and d illustrate a selected strut covered by a neointimal thickness of 
390 m, while the measured length of the strut from the Micro-CT image is 199 m, strut 
length measured from the corresponding IVOCT image is 275 m. Thin neointima did not 
have an impact the apparent length of the strut in the IVOCT image (Figure 5.13-a and b).   
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Figure 5.13: Effect of neointima on strut size; a) IVOCT and b) Micro-CT images of thin 
neointima, c) IVOCT and d) Micro-CT images of thick neointima where 
merry-go-round effect is observed. 
The effect of neointimal coverage on the appearance of the strut is demonstrated in 
Figure 5.14. Increase in neointimal thickness results in stent strut elongation as reflected 
light is scattered inside the neointima and collected by neighboring A-scans. Since these 
signals do not correspond to the actual stent surface, no shadowing is observed behind 
elongated strut edges in thicker neointima. 
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Figure 5.14: Simulated B-scans in presence of neointima: a) 50 m thick, b) 400 m thick 
Optical simulations validate the mechanism of the merry-go-round effect; as 
neointimal layer becomes thicker, reflections from the strut surface undergo multiple 
scattering events and are collected by the IVOCT catheter. Therefore, struts in the IVOCT 
image appear elongated and the arterial wall is seen behind the artifactually formed edges 
while shadowing is confined to the mid portion of the strut.  
SUNFLOWER WITH THICK NEOINTIMA 
Effect of catheter eccentricity was studied by acquiring images at different catheter 
offsets at a fixed longitudinal position. In presence of a 200 micron thick neointima, 
sunflower effect was not observed. Measurements for four selected struts (Figure 5.15-a) 
showed catheter eccentricity does not impact neointima thickness measurements 
significantly (Table 5.1).  
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Figure 5.15: Sunflower effect is not observed in presence of thick neonitmas, catheter 
positions: a) P1, b) P2, c) P3, and d) P4. 
 
Strut/Offset  P1 P2 P3 P4 
S-1 223.81 225.23 304.10 229.81 
S-2 194.54 194.97 196.26 192.10 
S-3 176.40 181.66 185.69 179.89 
S-4  209.52 213.27 214.67 207.51 
Table 5.1: Effect of catheter eccentricity on neointima thickness measurements (m) 
The effect of neointimal coverage on the strut appearance in IVOCT images is 
demonstrated in Figure 5.14 in form of B-scans. Strut covered by neonitimal layer shown 
in Figure 3.10-c was assumed at four catheter eccentric positions (P5-P8)  shown in Figure 
3.10-b. Neointimal boundary appears at the top of the image with the underlying stent strut. 
The neointima becomes tilted as the catheter is placed at more eccentric positions while 
the strut appears oriented parallel to neointimal surface. Because neointimal surface 
roughness was not included in the model, weaker signals are observed at P7 and P8. 
Reflected light can undergo multiple scattering events inside neointima and therefore 
reflections from more regions on the strut are coupled into the catheter while the initial 
direction of reflections deviate from a specularly reflected incoming beam. As a result, in 
this circumstance sunflower effect does not occur and strut size and orientation are 
unaffected.  
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Figure 5.16: Strut size and orientation vs. catheter eccentricity in presence of thick 
neointima: a) P5 (𝑟𝑐 = 0 mm), b) P6 (𝑟𝑐 = 0.3 mm), c) P7 (𝑟𝑐 = 0.6 mm), d) P8 
(𝑟𝑐 = 0.95 mm). 
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Chapter 6: Bioabsorbable stents 
CURRENT STATUS OF BIOABSORBABLE STENTS 
Metallic stents are permanent supports with a polymer coating eluting drug over 
two months. The need for vessel support and drug delivery is temporary and permanent 
support is unnecessary after the vessel has healed. Metallic stents in the long run may cause 
late stent thrombosis, expansive remodeling, side-branch obstruction by struts, difficulty 
in repeat surgical or percutaneous treatments and non-invasive imaging of coronary arteries 
with computed tomography or magnetic resonance [53-54].  
Bioabsorbable drug-eluting stents are an alternative approach, providing short-term 
vessel scaffolding as well as drug delivery capability. After stent degradation, the vessel is 
returned to its natural functionality without a foreign body causing inflammation and less 
potential for late stent thrombosis [54-55]. The concerns with bioabsorbable stents include 
time and rate of degradation, biocompatibility, biodegradable products, elution of the drug, 
radial force and late recoil [55]. Degradation of a bioabsorbable stent should occur in a 
reasonable time period since stents must maintain their support strength for 6 months to 
reduce restenosis [56-58].  
Tamai et al. [59] first examined the safety and feasibility of the bioabsorbable Igaki-
Tamai stent (Igaki Medical Planning Co, Kyoto, Japan) in humans in 2000. Igaki-Tamai is 
a non-drug-eluting stent made of poly-L-lactic acid monofilament. The 6-month follow-up 
of all patients showed acceptable restenosis. Erbel et al. [60] reported the outcome of a 
bioabsorbable magnesium stent (BIOTRONIK, Berlin, Germany) in which stents safely 
degraded after 4 months. However, the recoil that was recorded with this stent resulted in 
a high restenosis rate, precluding further clinical use. Ormiston et al. [54] demonstrated the 
feasibility and safety of Absorb everolimus-eluting stent (Abbott Vascular, Santa Clara, 
CA). Absorb is made from a bioabsorbable poly-L-lactic acid which is coated with a more 
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rapidly absorbed poly-D,L-lactic acid layer that contains and controls the release of 
everolimus. Haude et al. [61] reported safety of a Drug (Paclitaxel) Eluting Absorbable 
Magnesium Scaffold (DREAMS). Results showed completion of the bioabsorption at 6 
months with acute behavior that was comparable to conventional stents.  
IVOCT IMAGES OF BIOABSORBABLE STENTS 
In IVOCT images of bioabsorbable stents, struts appear as empty boxes where 
shadows are only seen along the two sides. Figure 6.1 illustrates IVOCT images of Absorb 
stent deployed in a phantom vessel recorded by a CoreVue system in our laboratory.  
 
Figure 6.1: a) IVOCT image of a 3 mm Absorb coronary stent deployed in phantom vessel 
with centered catheter, b) IVOCT image of the phantom vessel with catheter 
adjacent to the luminal wall, orientation of struts is not affected by catheter 
eccentricity. 
Stent struts do not always appear as a square or rectangular shape in IVOCT images 
which may be perceived as an imaging artifact. Micro-CT images of the Absorb stent 
(Figure 6.2) illustrates the actual shape of the struts where they are trapezoid and 
parallelogram shaped. Micro-CT images of the entire stent, also shows structure of 
bioabsorbable stent is not symmetric as compared to a metallic stent.   
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Figure 6.2: Micro-CT images of Absorb stent showing examples of a) a trapezoid shaped 
strut, b) a parallelogram shaped strut.  
In some IVOCT images bright spots are observed inside the struts (Figure 6.3-a) 
that some hypothesized to be micro fractures formed in the structure of bioabsorbable stent 
due to stress possibly caused by tortuosity of the coronary arteries, the deployment or 
degradation process. However, micro-CT images of the Absorb stent (Figure 6.3-b) suggest 
that these bright spots correspond to the hollow spaces between the struts when they 
separate or merge together. These hollow spaces will act as strong scattering centers which 
would produce the bright spots observed inside the struts (Figure 6.3-a). 
 
Figure 6.3: a) IVOCT image of a 3 mm Absorb coronary stent deployed in phantom 
vessel, b) Micro-CT image of the stent. 
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OPTICAL PROPERTIES OF STENT SURFACES 
The distinct appearance of bioabsorbable stents in IVOCT images is due to optical 
properties of the strut surface. To examine the differences between metallic and 
bioabsorbale stents in IVOCT images, optical properties of the strut surfaces in a reflection 
model were characterized.   
Surface reflection model 
He et al. [62] described a light reflection model for an arbitrary medium in terms of 
bidirectional reflectivity 𝜌, consisting of three components:  
𝜌 = 𝜌𝑠𝑝 + 𝜌𝑑𝑑 + 𝜌𝑢𝑑  (6.1) 
where 𝜌𝑠𝑝, 𝜌𝑑𝑑 and 𝜌𝑢𝑑  correspond to specular reflection, directional-diffuse and uniform-
diffuse reflections, respectively. Figure 6.4 illustrates a general reflecting surface. The 
specular and directional-diffuse terms correspond to first-surface reflection while the 
uniform-diffuse corresponds to light that enters the medium, scatters and re-emerges. 
 
 
Figure 6.4: example of light intensity for a general reflecting surface [62] 
Specular term accounts for mirror-like reflection from the mean plane of the 
reflecting surface: 
𝜌𝑠𝑝 ∝ |𝐹|
2. 𝑒−𝑔 = 𝜌𝑠𝑝
′   (6.2) 
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where |𝐹|2 is the Fresnel’s reflectivity and for a normally incident light is defined by 
refractive indices of the two media: 
 |𝐹|2 =
(𝑛𝑖−𝑛𝑡)
2
(𝑛𝑖+𝑛𝑡)2
 (6.3) 
and 𝑔 is a function of the surface roughness given by: 
𝑔 = (
4𝜋𝜎
𝜆
)
2
 (6.4)  
where 𝜎 is rms roughness of the surface and 𝜆 is the wavelength of incident light. 
Directional diffuse term corresponds to diffraction scattering by a rough surface:  
𝜌𝑠𝑝 ∝ |𝐹|
2.
𝜋 𝜏2
4 𝜆2
. ∑
𝑔𝑚  𝑒−𝑔
𝑚! 𝑚
𝑒
−
4 𝜋2 𝜏2
𝑚 𝜆2∞𝑚=1 = 𝜌𝑠𝑝
′  (6.5) 
where 𝜏 is the autocorrelation length of the surface height variations. Uniform diffuse term 
is attributed to multiple surface and/or subsurface reflections, specified by Lambertian 
distribution and does not contribute to the surface features of bioabsorbable stents in 
IVOCT images. 
Parameters required to characterize surface reflection properties include 𝜎 and 𝜏 
which can be calculated directly from surface profile and refractive indices of the surface 
material and the surrounding medium. In this study, surface profiles of Cypher (metal) and 
Absorb (bioabsorbable) stents were obtained by atomic force microscopy at resolution of 
few nanometers to find 𝜎 and 𝜏.    
Determining surface parameters   
Atomic force microscopy 
Atomic force microscopy (AFM) is based on sensing the force on a sharp stylus 
created by the proximity to the surface of the sample. The interatomic forces induce the 
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displacement of the stylus, and in its original implementation, a tunneling junction was 
used to detect the motion of a diamond stylus attached to an electrically conductive 
cantilever beam [63]. Meyer and Amer [64] introduced an optical approach in which the 
cantilever displacement is measured by detecting the deflection of a weak laser beam which 
is reflected off its backside. Stylus which is located at the end of a lever made of material 
with extremely low stiffness is maintained in contact with the surface under very small 
loads - typically in the order of 1 nN [65]. The force 𝐹 is measured by detecting the static 
deflection of the cantilever as its approaches the sample surface (𝐹 = ∆𝑧 𝑘 where ∆𝑧 is the 
cantilever displacement from its equilibrium position and 𝑘 is its force constant). As the 
tip is moved across the surface, a control feedback system constantly adjusts the tip to keep 
constant deflection. This adjustment represents the surface height variation.  
 
Figure 6.5: Schematic of AFM [66]. 
Stent surface profiles 
Pieces of Absorb and Cypher stents strut were cut and secured on glass slides. A 
Pointprobe® (NANOSENSORSTM, Neuchatel, Switzerland) with tip radius of less than 7 
nm was used to scan the samples [67]. Surface areas of 10×10 m2 were scanned, acquiring 
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128×128 points which provided images with resolution of 78.12 nm. Figure 6.6 illustrates 
the measured variation in surface height of the two stent struts.   
  
Figure 6.6: Surface profile: a) Absorb (bioabsorbable) and b) Cypher (metallic) stents. 
Surface roughness found from AFM measured surface profiles of Absorb and 
Cypher were 𝜎𝑎= 55.67 nm and 𝜎𝑐= 123.79 nm, respectively. Auto correlation of the 
surface profiles was calculated and the full-width-half-maximum was measured. 
Correlation length of Absorb was 𝜏𝑎= 1.17 m. Auto correlation profile of Cypher was 
anisotropic and the mean of correlation lengths was assumed 𝜏𝑐= 2.58 m.   
Refractive index measurement 
Refractive index of Absorb was measured using an OCT system. A stent strut was 
secured on a glass slide and an OCT scan was recorded. Distance between the two 
reflections from air-polymer and polymer-air interfaces were taken as OPL and the distance 
from air-polymer to the reflection from glass slide was taken as the corresponding physical 
path length since the light traveled through air. Refractive index of Absorb was calculated 
by dividing OPL by the physical length which was 1.4.  
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Comparison of stent surface reflections  
Specular and directional diffuse primed reflectivity of Absorb and Cypher stents 
were calculated using Eqs. 6.2 and 6.5. Fresnel reflection coefficient of Absorb was found 
using the measured refractive index 𝑛𝑎 = 1.40 and assuming contrast flush for surrounding 
medium (𝑛𝑎 = 1.45), giving |𝐹|
2 = 3.7×10-4. Cypher stent is composed of stainless steel 
with reported refractive index of 𝑛 = 4.1 + 5.8𝑖 [68]. Computed Fresnel reflectivity for 
normal incidence is |𝐹|2 = 0.79. Specular (𝜌𝑠𝑝
′ ) and directional diffuse (𝜌𝑑𝑑
′ ) primed 
reflectivity of Cypher and Absorb stents are given in Table 6.1 
 
 𝝆𝒔𝒑
′  𝝆𝒅𝒅
′  
Cypher 0.19 5.53×10-13 
Absorb 2.78×10-4 1.24×10-11 
Table 6.1: Specular (𝜌𝑠𝑝
′ ) and directional diffuse (𝜌𝑑𝑑
′ ) primed reflectivities of Cypher 
and Absorb stents. 
Magnitude of the primed reflectivity does not directly give the magnitude of the 
reflected light without accounting for the incident and reflected solid angles, nonetheless, 
relative values of primed reflectivity provide a basis to describe the appearance of the 
Absorb and Cypher stents in IVOCT images. Specular primed reflectivity of Cypher is 
almost three orders of magnitude larger than the Absorb, and therefore, strong specular 
reflections from metal stent surfaces are recorded which are dependent on the direction of 
incident beam. IVOCT images of metallic stents do not normally show specular reflection 
of the strut sides since the surface normal does not match the direction of incoming light. 
Relative magnitude of directional diffuse to specular primed reflectivity is much larger for 
Absorb which is consistent with observations of Absorb struts where light backscattered 
from the strut sides is observed. The relative contribution of the directional diffuse 
component to observed strut surfaces in IVOCT images is larger for the Absorb compared 
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to Cypher. Since the IVOCT beam orientation does not affect the appearance of struts, 
sunflower artifact is not observed when the catheter is at eccentric positions. Additionally, 
no reflection is recorded at depths corresponding to the inside of the struts due to optical 
homogeneity of the polymer comprising the strut. This allows the reflection at arterial wall 
boundary to be recorded and shadows only form along the two sides of the struts.       
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Chapter 7: Metal Stent Artifact Correction Algorithm 
ALGORITHM OUTLINE 
The objective of these studies is to develop an algorithm to replace the apparent 
struts rendered from IVOCT images of a metallic stent recorded from one pullback with 
the actual stent structure based on Micro-CT imaging.  
 
Figure 7.1: Approach for artifact construction algorithm. a) IVOCT image of CYPHER® 
stent deployed in a phantom vessel demonstrating sunflower and merry-go-
round artifacts, b) CYPHER® stent imaged by Micro-CT, c) Corrected 
IVOCT image with artifacts removed. 
The stent size and orientation as recorded by Micro-CT and recorded IVOCT 
images are utilized to correct for strut artifacts. A flow diagram of the proposed algorithm 
is demonstrated in Figure 7.2. 
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Figure 7.2: Block diagram of the correction algorithm; top left: Micro-CT data is 
processed by first down sampling, rendering in three-dimensions, applying an 
edge filter and deriving dataset 𝑣𝑀𝐶𝑇, top right: IVOCT images of a pullback 
are rendered and struts are segmented, obtaining dataset 𝑣𝐼𝑉𝑂𝐶𝑇, bottom: an 
error function is minimized by iteratively changing transformation parameters 
which are applied to 𝑣𝑀𝐶𝑇. The best overlap achieved by 𝑣𝑀𝐶𝑇
′  gives an 
artifact-free image of strut size and apposition.  
Micro-CT images are rendered and must first be down-sampled since their voxel 
size is about 10-fold finer than that of IVOCT images. After down sampling, an edge filter 
is applied to stent struts in the Micro-CT image to find the inner surface of struts and x, y 
and z coordinate locations and surface normals of the selected points for storage in  𝑉𝑀𝐶𝑇. 
IVOCT images of a pullback are rendered and apparent struts in a deployed stent are 
obtained using image segmentation, giving a three-dimensional representation of the 
apparent stent struts and x, y and z coordinate locations be will stored in 𝑉𝐼𝑉𝑂𝐶𝑇. Objective 
of the algorithm is to determine the values of the transformation parameters that provide 
the best overlap between 𝑉𝐼𝑉𝑂𝐶𝑇 and 𝑉𝑀𝐶𝑇The transformation parameters are determined 
by minimizing an error function (Eq. 7.1). 
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𝐸𝑟𝑜𝑟𝑟 (𝑝) =  ∑ (𝑉𝐼𝑉𝑂𝐶𝑇 − 𝑉𝑀𝐶𝑇(𝑝))
2
𝑖,𝑗,𝑘   (7.1) 
where 𝑝 is an array of transformation parameters. Having found the parameters, Micro-CT 
data set is transformed and inserted into the IVOCT image to give an artifact-free image of 
strut size and apposition.  
STENT DATABASE 
Micro-CT images of a CYPHER® stent were used to reconstruct a three-
dimensional representation of the whole strut which was stored in a stereolithography 
(STL) file format. STL files define geometry of an object by breaking down the surface 
into triangles, also called facets (Figure 7.3). Each facet is described by coordinate 
locations of the three vertices and direction of the surface normal.   
 
Figure 7.3: Three dimensional model of CYPHER® stent stored in STL file, close up: 
triangles defining the stent surface. 
Using a reader [69], STL file data was imported into MATLAB by creating three 
matrices shown in Figure 7.4: 
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Figure 7.4: Reading an STL file in MATLAB.  Number of triangles is denoted by m.  In 
the Nodes matrix, the m’th row represents the vertices of the m’th triangle.  
Each row in the Vertices matrix represents coordinates (x,y,z) of one vertex.  
The m’th row of the Normals matrix represents the unit normal to the m’th 
triangle.    
Node numbers of each triangle is listed in one row of matrix Nodes, where m is the 
total number of triangles, (x,y,z) coordinates of each node can be found in the Vertices 
matrix. The m’th row of the vertices number is equivalent to the node number. The surface 
normal of each triangle is stored in matrix Normals, at a row number equivalent to the 
triangle number. Vertices coordinate locations of each triangle were averaged and stored 
in an m×3 array as stent position data 𝑆𝑝 and the corresponding surface normal was stored 
as the stent normal data 𝑆𝑛 . When imaging a deployed stent within an artery, IVOCT 
catheter only collects reflections from the inner surface of the stent. Consequently, 
positions and normals of triangles forming the outer surface of the stent were omitted from 
stent database (Figure 7.5). 
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Figure 7.5: Imported CYPHER® stent positions into MATLAB, selected inner surface for 
simulating pullback are shown in yellow. 
GLOBAL COORDINATE SYSTEM FOR STENT DATABASE  
Stent database obtained from STL file is taken as the global coordinate system in 
which the pullback is simulated. Stent orientation and center of mass, shown in Figure 7.6 
were used for coordinate transformation.   
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Figure 7.6: a) Stent orientation (𝜑𝑠 and 𝜃𝑠) and center of mass (𝑝𝑐𝑚) in global coordinate 
system (black axes), simulated pullback is generated in local coordinate 
system (green axes) and transformed to global coordinate system using 𝜑𝑠, 𝜃𝑠 
and pcm, b) finding 𝜑𝑠 and 𝜃𝑠 values. 
Center of mass (𝑝𝑐𝑚) was calculated by Eq.7.2 and utilized to translate the local 
coordinate system along 𝑥 and 𝑦 axes. The 𝑧 axis was translated by (𝑧𝑐𝑚 − 𝑧𝑚𝑖𝑛) where 
𝑧𝑚𝑖𝑛  was the minimum 𝑧 coordinate of stent database that has only positive 𝑧 values. 
𝑥𝑐𝑚 = (∑ 𝑥𝑖
𝑚
𝑖=1 ) 𝑚⁄   ,   𝑦𝑐𝑚 = (∑ 𝑦𝑖
𝑚
𝑖=1 ) 𝑚⁄   ,   𝑧𝑐𝑚 = (∑ 𝑧𝑖
𝑚
𝑖=1 ) 𝑚⁄   (7.2) 
Stent orientation was described by two angles 𝜑𝑠, representing a rotation about 𝑧 
axis and 𝜃𝑠, a rotation about 𝑥 axis which were calculated by taking a point (𝑝) on the 𝑧 
axis of local coordinate system and finding the corresponding coordinate location in global 
coordinate system: 
𝜑𝑠 = tan
−1 𝑦𝑝 𝑥𝑝⁄   (7.3) 
𝜃𝑠 = tan
−1 √𝑥𝑝
2 + 𝑦𝑝
2 𝑧𝑝⁄   (7.4) 
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where 𝑥𝑝, 𝑦𝑝, and 𝑧𝑝the coordinate locations of 𝑝 in global coordinate sysyem. 
LOCAL TO GLOBAL COORDINATE TRANSFORMATION 
Local coordinate system in which a helix function is generated is transformed to 
the global coordinate system. The helix function represents angular orientation of the light 
beam exiting the IVOCT catheter. Transformation parameters include a translation by the 
stent center of mass and Euler angle rotations to account for the stent orientation.  
Euler’s angles 
Euler angles, typically denoted by 𝜑, 𝜃, 𝜓 are used to represent the orientation of a 
coordinate system relative to another. Euler angles correspond to a sequence of three 
rotations about the axes of a coordinate system, starting from a known standard orientation 
(Figure 7.7). Any rotation matrix R can be decomposed as a product of three elemental 
rotation matrices A, B and C given by Eq.6.5 and 6: 
  
Figure 7.7: Coordinate rotation with the Euler angles 𝜑, 𝜃, 𝜓 [70] 
𝐶 = [
   𝑐𝑜𝑠 𝜑   𝑠𝑖𝑛 𝜑    0
−𝑠𝑖𝑛 𝜑   𝑐𝑜𝑠 𝜑   0
      0           0        1
] ,   𝐵 = [
1          0          0  
 0      𝑐𝑜𝑠 𝜃  𝑠𝑖𝑛 𝜃
  0 − 𝑠𝑖𝑛 𝜃   𝑐𝑜𝑠 𝜃
] ,   𝐴 = [
   𝑐𝑜𝑠 𝜓   𝑠𝑖𝑛 𝜓    0
−𝑠𝑖𝑛 𝜓   𝑐𝑜𝑠 𝜓    0
      0           0        1
] (7.5) 
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𝑅 = 𝐴𝐵𝐶 (7.6) 
     = [
   𝑐𝑜𝑠 𝜓 𝑐𝑜𝑠 𝜑 − 𝑐𝑜𝑠 𝜃 𝑠𝑖𝑛 𝜑 𝑠𝑖𝑛 𝜓       𝑐𝑜𝑠 𝜓 𝑠𝑖𝑛 𝜑 + 𝑐𝑜𝑠 𝜃 𝑐𝑜𝑠 𝜑 𝑠𝑖𝑛 𝜓      𝑠𝑖𝑛 𝜓 𝑠𝑖𝑛 𝜃 
−𝑠𝑖𝑛 𝜓 𝑐𝑜𝑠 𝜑 − 𝑐𝑜𝑠 𝜃 𝑠𝑖𝑛 𝜑 𝑐𝑜𝑠 𝜓    −𝑠𝑖𝑛 𝜓 𝑠𝑖𝑛 𝜑 + 𝑐𝑜𝑠 𝜃 𝑐𝑜𝑠 𝜑 𝑐𝑜𝑠 𝜓    𝑐𝑜𝑠 𝜓 𝑠𝑖𝑛 𝜃
                  𝑠𝑖𝑛 𝜃 𝑠𝑖𝑛 𝜑                                                   −𝑠𝑖𝑛 𝜃 𝑐𝑜𝑠 𝜑                            𝑐𝑜𝑠 𝜃
]  
DEFINING HELIX 
Functions describing coordinates of a circular helix 𝐻𝑝 with radius 𝑟 and the 
normals 𝐻𝑛 are defined by   
𝐻𝑝(𝑡) = [
𝑟 𝑐𝑜𝑠 𝜑
𝑟 𝑠𝑖𝑛 𝜑 
𝑐 𝑡
]  (7.7) 
𝐻𝑛(𝑡) = [
−𝑐𝑜𝑠 𝜑
−𝑠𝑖𝑛 𝜑
0
]   (7.8) 
𝜑 = 2𝜋𝑓𝑡  (7.9) 
where 𝜑 is the phase, 𝑓 is catheter rotation speed (rpm), 𝑡 is pullback time (s), 𝑐 is the 
pullback speed (mm/s). To simulate the effect of catheter position and orientation and the 
position of the starting A-scan on the generated pullback, 𝐻𝑝 and 𝐻𝑛 functions are modified 
by introducing variables that correspond to each effect; the position of the first A-scan is 
given by 𝑧𝑝 and 𝜑𝑝 causing an offset along the catheter and a phase offset, respectively 
𝐻𝑝(𝑡) = [
𝑟 𝑐𝑜𝑠(𝜑 + 𝜑𝑝)
𝑟 𝑠𝑖𝑛(𝜑 + 𝜑𝑝)
 𝑐 𝑡 + 𝑧𝑝
]  (7.10) 
𝐻𝑛(𝑡) = [
− 𝑐𝑜𝑠(𝜑 + 𝜑𝑝)
− 𝑠𝑖𝑛(𝜑 + 𝜑𝑝)
0
]  (7.11) 
catheter position is given by 𝑥𝑐 and 𝑦𝑐  from the center results in a translation in the helix 
function 
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𝐻𝑝(𝑡) =  [
𝑟 𝑐𝑜𝑠(𝜑 + 𝜑𝑝) + 𝑥𝑐
𝑟 𝑠𝑖𝑛(𝜑 + 𝜑𝑝) + 𝑦𝑐
𝑐 𝑡 + 𝑧𝑝
]  (7.12) 
and catheter orientation defined by two angles 𝜑𝑐 and 𝜃𝑐 (assuming 𝜓𝑐 = 0) results in a 
coordinate rotation which can be described using Euler’s angles (Eq.7.6), multiplying 
𝐻𝑝(𝑡) and 𝐻𝑛(𝑡) by rotation matrix 𝑅𝑐  the modified helix considering all variables is 
obtained 
𝐻𝑝(𝑡)
= [
𝑐𝑜𝑠 𝜑𝑐 [ 𝑟 𝑐𝑜𝑠(𝜑 + 𝜑𝑝) + 𝑥𝑐] +  𝑠𝑖𝑛 𝜑𝑐 [ 𝑟 𝑠𝑖𝑛(𝜑 + 𝜑𝑝) + 𝑦𝑐] 
−𝑐𝑜𝑠 𝜃𝑐 𝑠𝑖𝑛 𝜑𝑐 [ 𝑟 𝑐𝑜𝑠(𝜑 + 𝜑𝑝) + 𝑥𝑐] +𝑐𝑜𝑠 𝜃𝑐 𝑐𝑜𝑠 𝜑𝑐 [ 𝑟 𝑠𝑖𝑛(𝜑 + 𝜑𝑝) + 𝑦𝑐] + 𝑠𝑖𝑛 𝜃𝑐 (𝑐 𝑡 + 𝑧𝑝)
𝑠𝑖𝑛 𝜃𝑐 𝑠𝑖𝑛 𝜑𝑐 [ 𝑟 𝑐𝑜𝑠(𝜑 + 𝜑𝑝) + 𝑥𝑐] −𝑠𝑖𝑛 𝜃𝑐 𝑐𝑜𝑠 𝜑𝑐 [ 𝑟 𝑠𝑖𝑛(𝜑 + 𝜑𝑝) + 𝑦𝑐] + 𝑐𝑜𝑠 𝜃𝑐 (𝑐 𝑡 + 𝑧𝑝)
]       
(7.13) 
𝐻𝑛(𝑡) = [
− 𝑐𝑜𝑠 𝜑𝑐 𝑐𝑜𝑠(𝜑 + 𝜑𝑝) − 𝑠𝑖𝑛 𝜑𝑐 𝑠𝑖𝑛(𝜑 + 𝜑𝑝) 
𝑐𝑜𝑠 𝜃𝑐 𝑠𝑖𝑛 𝜑𝑐 𝑐𝑜𝑠(𝜑 + 𝜑𝑝) −𝑐𝑜𝑠 𝜃𝑐 𝑐𝑜𝑠 𝜑𝑐 𝑠𝑖𝑛(𝜑 + 𝜑𝑝)
−𝑠𝑖𝑛 𝜃𝑐 𝑠𝑖𝑛 𝜑𝑐 𝑐𝑜𝑠(𝜑 + 𝜑𝑝) +𝑠𝑖𝑛 𝜃𝑐 𝑐𝑜𝑠 𝜑𝑐 𝑐𝑜𝑠(𝜑 + 𝜑𝑝)
]  (7.14) 
SIMULATED PULLBACK 
Generated helix positions and normals based on given parameters were utilized to 
simulate a pullback from the stent dataset. To find the reflecting region of the stent that is 
recorded by each A-scan, first the stent regions whose normals’ direction is within an 
accepted angular tolerance of the A-scan’s normal are determined first. This was done by 
calculating the dot product of the A-scan’s direction with all the stent normals which gives 
the angle between two directions since their magnitudes are one (Eq.7.15). The accepted 
angular tolerance represents change in wavefront normal for the OCT light assumed to be 
a Gaussian beam. 
𝑆𝑛. 𝐻𝑛 = |𝑆𝑛||𝐻𝑛| 𝑐𝑜𝑠 𝜃 < 𝑐𝑜𝑠(𝜋 − 𝛼) (7.15) 
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where 𝐻𝑛 is the helix normal, 𝑆𝑛 is the stent normal, 𝜃 is the angle between the normals, 
and 𝛼 is the accepted angular tolerance. As multiple helix positions with equivalent 
normals exist, not all stent positions whose normal meet this condition correspond to the 
helix position. Therefore, only the positions that are within in an accepted distance from 
the intersection of A-scan and stent. Figure 7.8 illustrates the generated helix, stent and a 
selected A-scan represented by a helix position 𝐻𝑝,𝑖  and surface normal 𝐻𝑛,𝑖.   
 
Figure 7.8: Simulated pullback; a selected A-scan is indicated by helix position 𝐻𝑝,𝑖  and 
surface normal 𝐻𝑛,𝑖, accepted stent position 𝑆𝑝,𝑗 within distance 𝑑 from 𝐻𝑛,𝑖. 
Distance, denoted by 𝑑, is defined and constrained by 
𝑑 = |(𝑆𝑝 − 𝐻𝑝) − [(𝑆𝑝 − 𝐻𝑝). 𝐻𝑛]𝐻𝑛| < 𝛽  (7.16) 
where 𝑆𝑝 is the stent position, 𝐻𝑝 is the helix position, 𝐻𝑛 is the helix normal, and 𝛽 is the 
accepted distance range. The accepted distance represents spot-size of the Gaussian beam 
that was approximated as a constant.  
Stent positions that meet the criteria in Eqs. 7.15 and 7.16 are included in the 
simulated pullback data. Depending the catheter parameters, number of selected points on 
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the stent could vary. To keep the size of simulated pullback constant, an array (?̂?) was 
defined for the output B-scan data.  The index of the ?̂? array corresponds to the A-scan # 
while the value in the array corresponds to distance of the strut (if present) from the 
catheter.  If no strut is present for a particular A-scan then a value of zero is assigned at 
that index (Figure 7.9).  
 
Figure 7.9: Selected subset of simulated B-scan (?̂?); in A-scan 1 (#265) light was 
reflected and depth of strut 0.67 mm was stored, in A-scan 2 (#458) no stent 
positions were found from which light was reflected and therefore a zero was 
assigned.  
OBJECTIVE FUNCTION 
The objective function to be fitted to an IVOCT pullback was defined in Matlab as 
follows:   
 Pullback data (catheter rotation frequency (𝑓), pullback speed (𝑐) and pullback 
duration (𝑡). are provided to generate the helix function.  
 Catheter position (𝑥𝑐 and 𝑦𝑐), catheter orientation (𝜑𝑐 and 𝜃𝑐) and position of first 
A-scan (𝑧𝑝 and 𝜑𝑝) are used to modify the helix in the local coordinate system.  
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 Helix function is transformed to the global coordinate system using stent center of 
mass (𝑥𝑐𝑚, 𝑦𝑐𝑚 , and 𝑧𝑐𝑚) and stent orientation (𝜑𝑠 and 𝜃𝑠). 
 Pullback is simulated using the Helix function and stored stent database. 
Figure 7.10 illustrates two examples of a simulated pullback where all parameters 
are assumed 0 (top) and where parameters are 𝑥𝑐 = 0.05, 𝑦𝑐  = 0.05, 𝜑𝑐 = /8, 𝜃𝑐 = /15, 𝑧𝑝 
= 0.1, and 𝜑𝑝 = /4 (bottom). 
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Figure 7.10: Examples of two simulated pullbacks: a) 3D representation of pullback 1 
where all parameters (𝑥𝑐, 𝑦𝑐 , 𝜑𝑐, 𝜃𝑐, 𝑧𝑝, and 𝜑𝑝) are zero, b) a selected 
simulated B-scan (?̂?), c) 3D representation of pullback 2 with parameters 𝑥𝑐 
= 0.05, 𝑦𝑐  = 0.05, 𝜑𝑐 = /8, 𝜃𝑐 = /15, 𝑧𝑝 = 0.1, and 𝜑𝑝 = /4, d) selected 
simulated B-scan corresponding to selected B-scan in b.  
LEVENBERG-MARQUARDT ALGORITHM 
The Levenberg-Marquardt algorithm is a standard technique used to solve 
nonlinear optimization problems which involve an iterative improvement to parameter 
values in order to reduce the sum of the squares of the errors between an objective function 
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and the measured data points [71-72]. Assuming data points are denoted by 𝑦 =
(𝑦1 , 𝑦2 , … , 𝑦𝑛) and the model to be fitted is given by ?̂? = 𝑓(𝑥1, 𝑥2, … , 𝑥𝑛, 𝑝1 , 𝑝2, … , 𝑝𝑚), 
where 𝑥𝑖 is i
th independent variable and 𝑝𝑖  is the i
th parameter, the objective is to compute 
estimates of the parameters which will minimize  ∑|𝑦 − ?̂?|2. The scalar-valued goodness-
of-fit measure is called the chi-squared error criterion given by  
𝜒2(𝑝) =
1
2
∑ [
𝑦𝑖−?̂?(𝑥𝑖,𝑝)
𝑤𝑖
]
2
𝑚
𝑖=1   
             =
1
2
(𝑦 − ?̂?(𝑝))
𝑇
𝑊(𝑦 − ?̂?(𝑝))  (7.17) 
where 𝑤𝑖  is a measure of the error in measurement 𝑦𝑖  and weighting matrix 𝑊 is diagonal 
with 𝑊𝑖𝑖 = 1 𝑤𝑖
2⁄  [71]. Since function ?̂? is nonlinear in the model parameters 𝑝, the 
minimization of 𝜒2 must be carried out iteratively, by applying a perturbation ℎ to the 
parameters at each iteration. 
The Levenberg-Marquardt algorithm is a combination of two minimization 
methods: the steepest gradient descent and the Gauss-Newton method. The algorithm 
behaves like a steepest descent method when the parameters are far from the optimal values 
and it becomes a Gauss-Newton method when parameters are close to the optimal values 
[73].  
Steepest gradient descent Method 
The steepest gradient descent is a general minimization method which updates 
parameter values in the direction opposite to the gradient of the objective function. It is 
recognized as a highly convergent algorithm for finding the minimum of simple objective 
functions [72, 74]. The gradient of the chi-squared objective function with respect to the 
parameters is given by  
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𝜚
𝜚𝑝
𝜒2(𝑝) = (𝑦 − ?̂?(𝑝))
𝑇
𝑊 
𝜚
𝜚𝑝
(𝑦 − ?̂?(𝑝))  
                 = −(𝑦 − ?̂?(𝑝))
𝑇
𝑊 [
𝜚?̂?(𝑝)
𝜚𝑝
]  (7.18) 
where [𝜚?̂?(𝑝) 𝜚𝑝⁄ ] represents the local sensitivity of ?̂? variation in the parameters, also 
called Jacobian matrix (𝐽). The perturbation ℎ that moves the parameters in the direction 
of steepest descent is given by 
ℎ𝑔 = 𝛼𝐽
𝑇𝑊(𝑦 − ?̂?)  (7.19) 
where the positive scalar 𝛼 determines the length of the step in the steepest-descent 
direction. 
The Gauss-Newton Method 
The Gauss-Newton method is a method of minimizing a sum-of-squares objective 
function. Objective function is assumed quadratic in the parameters near the optimal 
solution. The function evaluated with perturbed model parameters may be approximated 
by first-order Taylor series expansion: 
?̂?(𝑝 + ℎ) ≈ ?̂?(𝑝) + [
𝜚?̂?
𝜚𝑝
] = ?̂? + 𝐽ℎ  (7.20) 
The perturbation ℎ that minimizes 𝜒2 is found by 𝜚𝜒2 𝜚ℎ⁄ =0 where ?̂? in Eq.6.17 is 
substituted by approximation for the perturbed function, ?̂? + 𝐽ℎ and the resulting normal 
equations for the Gauss-Newton perturbation are 
[𝐽𝑇𝑊𝐽]ℎ𝑔𝑛 = 𝐽
𝑇𝑊(𝑦 − ?̂?)  (7.21) 
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Levenberg-Marquardt method as a blend of steepest gradient descent  and Gauss-
Newton method 
The Levenberg-Marquardt algorithm varies the parameter updates between the 
steepest gradient descent and Gauss-Newton update: 
[𝐽𝑇𝑊𝐽 + 𝜆𝐼]ℎ𝑙𝑚 = 𝐽
𝑇𝑊(𝑦 − ?̂?)  (7.22) 
where small values of the algorithmic parameter 𝜆 result in a Gauss-Newton update and 
large values of 𝜆 result in a steepest gradient descent update. At a large distance from the 
function minimum, the steepest gradient descent method is utilized to provide steady and 
convergent progress toward the solution. As the solution approaches the minimum, 𝜆 is 
adaptively decreased and the Levenberg-Marquardt method approaches the Gauss-Newton 
method, and the solution typically converges rapidly to the local minimum [72-74]. 
IMPLEMENTING LEVENBERG-MARQUARDT ALGORITHM    
Matlab optimization toolbox (lsqcurvefit function) was utilized to apply the 
Levenberg-Marquardt algorithm. The objective function (?̂?), independent variables (𝑥),   
initial parameters (𝑝𝑜) and the data (𝑦) are specified, lsqcurvefit starts at 𝑝𝑜 and finds 
parameters 𝑝 to best fit the nonlinear objective function ?̂? = 𝑓(𝑥, 𝑝) to the data 𝑦 [75]. The 
objective function of this study does not take independent variables (𝑥) as input, only 
parameters (𝑝) are needed to generate a simulated pullback using the stent database. Since 
𝑦 and ?̂? are required to have equal sizes for error calculation, 𝑦 was defined to have a 
constant size regardless of the number of points in generated pullback, as described in 
section 7.6.  
To test the feasibility and accuracy of the method, a pullback generated with known 
parameters was assumed as 𝑦 and initial parameters that were close to the actual parameters 
was specified to start the Levenberg-Marquardt algorithm. One of the challenges of 
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optimization using this objective function, is the relatively large errors when parameters 
are far from the solution and a small change in parameters (Δ𝑝) used to find the Jacobian 
matrix does not make a necessary change in the calculated error and so the algorithm fails 
to converge. As a result, minimum Δ𝑝 was increased from 10-6 to 10-2 and the tolerance 
was increased from 10-6 to 10-4.  
Case 1: A pullback generated using parameter values: 𝑥𝑐 = 0.1 mm, 𝑦𝑐  = 0.1 mm, 
𝑧𝑝 = 0 mm, 𝜑𝑝 = 0 rad, 𝜑𝑐 = 0 rad, and 𝜃𝑐 = 5 rad was considered as data 𝑦1 and initial 
parameters (in the above order) was specified 𝑝𝑜 = [0.05, 0.05, 0, 0, 0, 0.20]. Using 𝜆=0.01 
(the default value), algorithm converged after 24 iterations (calling objective function 329 
times). Returned parameters were 𝑝𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 = [0.9999, 0.1000, 0, -0.0008, 0.007, 0.2500] 
with 𝜒2 = 13.80.   
Case 2: Data 𝑦1 defined in case 1 was considered with initial parameters further 
from actual values, 𝑝𝑜 = [0, 0, 0, 0, 0, 0]. Algorithm converged after 112 iterations (calling 
objective function 1482 times). Returned parameters were 𝑝𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 = [0.1, 0.1, 0, 0, 0, 
0.26] with 𝜒2 = 1043.39.  
Error analysis  
The calculated 𝜒2 includes two types of errors: 1) a mismatch between simulated 
(𝑦) and fitted (?̂?|𝑝) IVOCT pullbacks corresponding to when an A-scan in the simulated 
does not match the fitted or vice versa; and 2) A-scans that do intersect a strut in both 
simulated and fitted pullbacks, however, neighboring points on the strut deviate. Figure 
7.11-a illustrates the error between   and   over the entire pullback. Number of A-scans with 
non-zero value of error is 4258 where total number of A-scans is 100,000. 
 
 85 
 
Figure 7.11: a) Error between 𝑦 and ?̂?|𝑝 plotted over entire pullback (100,000 A-scans), 
b) selected B-scan (#97), c) close-up of error in -20 to 20 m range. 
Errors with an absolute value in range of 0.6 to 0.8 mm corresponds to mismatch 
of A-scans, giving 2272 data points. Considering each B-scan consists of 666 A-scans, 
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there are on average 3.5 mismatched A-scans in each B-scan (Figure 7.11-b). The rest of 
error data indicates deviation between neighboring points on the struts which results in a 
different depth recorded by A-scans. Figure 7.11-c illustrates a close-up of Figure 7.11-a 
in range of 2 to 20 m. Error values are bracketed by 10 m which is within resolution of 
IVOCT system.     
The test cases demonstrated the practicality of Levenberg-Marquardt algorithm for 
this optimization problem. A primary source of error between simulated and fitted IVOCT 
pullback corresponds to unmatched A-scans. Unmatched A-scans correspond to cases 
when either a strut is present in the simulated data and not present in the fitted data or when 
a strut is not presence in the simulated data and is in the fitted data. Inasmuch as missed 
struts are a primary source of error between simulated and fitted data, an alternative error 
function that accounts for variance in both dimensions (i.e., scan depth and A-scan number) 
in the IVOCT pullback should be considered. For example, an error function that does not 
severely penalize adjacent A-scans in simulated and fitted data that have a strut at 
approximately the same depth may provide improved results. 
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Chapter 8: Conclusions and discussions  
CONCLUSIONS 
The objective of my research was to characterize and correct artifacts associated 
with IVOCT images of coronary stents. IVOCT provides images at resolution of 10-15 um, 
making this technique a preferred assessment technique in coronary stenting, nevertheless, 
imaging artifacts have not been thoroughly studied. Clinical use of IVOCT to assess 
coronary stenting will benefit from the characterization and correction of various artifacts. 
In my research, two models were created; a physical blood vessel model to acquire images 
under controlled conditions and a computer model using physical and physiological based 
parameters to perform optical simulations. 
Sunflower effect 
The sunflower effect is observed when imaging metal coronary stents and appears 
as a bending of stent struts toward IVOCT catheter. Sunflower effect occurs when the 
catheter is at eccentric positions in the vessel lumen. Results of this work suggests when 
an eccentric IVOCT catheter emits light that is incident on a metal stent strut at any angle, 
returning light to the catheter is reflected from a small-sized region on the metal strut 
surface. The regions that reflect light back into the catheter have a surface normal that is 
oriented along the light direction. As light transmits from the catheter, a finite beam width 
at the stent strut ensures return reflections are recorded at each angular position. Since 
reflections return from a small-sized region on the stent strut, echo-time is nearly constant 
at each angular position and the metal strut appears in IVOCT images as a straight line 
bending towards the catheter.  
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Malapposition measurement 
Inasmuch as IVOCT stent measurements are at an early stage, no comprehensive 
consensus methodology exists on how to measure stent malapposition that is uniformly 
agreed upon. Results of this study confirms the accuracy of one the methods used in clinical 
practice in which the user draws a line-segment from center of the strut blooming in the 
IVOCT image to the luminal wall that indicates the shortest distance, malapposition is 
determined by subtracting the known strut thickness from the measured distance. 
Observation of all stent struts in the IVOCT image is proposed where a circle is drawn 
tracing the circumference of the stent and lines are drawn from the center of strut blooming 
to the arterial wall perpendicular to the circle and the measured malapposition distances 
match the actual values. 
Evaluation of IVOCT in neointima thickness measurement 
Measurements of neonitimal thickness from IVOCT images were compared to 
values obtained from Micro-CT images which represent actual neointimal thickness. We 
were able to measure the thickness of neointimal layers in IVOCT images as thin as 30 m 
accurately in presence of 5% blood. Fractional error in IVOCT measurements of thin and 
thick neointima was 0.03 and 0.27, respectively. User placement of a line segment results 
in larger errors when measuring thin neointimas, nonetheless an error of 10 m is within 
the resolution of IVOCT.   
Effect of thick neointimas 
Optical simulations validate the mechanism of the merry-go-round effect in 
presence of thick neointima; as the neointimal layer becomes thicker, reflections from the 
strut surface undergo multiple scattering events and are collected by the IVOCT catheter. 
Therefore, struts in the IVOCT image appear elongated and the arterial wall is observed 
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behind the artifactually formed edges while shadowing is confined to the mid portion of 
the strut. Similarly, when the catheter is at eccentric positions, multiple scattering events 
inside neointima results in recording reflections from more regions on the strut while the 
initial direction of reflections deviate from a specularly reflected incoming beam. 
Consequently, sunflower effect is not pronounced.  
Bioabsorbable stents 
Surface reflections of bioabsorbable and metallic stents were investigated. Specular 
reflection was the primary source of reflection in Cypher stent, resulting in strong 
reflections that are dependent on the direction of incident beam. In case of Absorb stent, 
directional diffuse is of the same order of magnitude compared to specular values, causing 
the incident beam to backscatter to the catheter regardless of the incident light direction. 
Consequently, reflections from the entire strut surface are observed and struts appear as 
empty boxes due to homogeneity of the polymer. Furthermore, Micro-CT images 
illustrated the bright spots inside struts corresponds to hollow spaces between the struts 
when they separate or merge together and do not necessarily indicate presence of micro 
fractures. Finally, Micro-CT images also suggest that shape of struts in IVOCT images can 
be artifactually deformed from the true shape. 
Artifact correction algorithm  
An algorithm was developed which replaces the apparent stent struts in IVOCT 
pullback images with the actual stent structure obtained by Micro-CT imaging. Simulated 
pullback was generated using a stent database and catheter position and orientation.  
Levenberg-Marquardt algorithm was ulitized to fit the simulated pullback to the actual 
IVOCT pullback data, by finding values of desired transformation parameters. Feasibility 
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and accuracy of this method was tested using a pullback generated with known parameters 
as IVOCT pullback data. 
FUTURE STUDIES  
Applying correction algorithm to IVOCT pullback  
Having shown the practicality of Levenberg-Marquardt algorithm by using 
simulated pullback as input data, the next step is using IVOCT pullback of phantom vessels 
where catheter position and orientation is controlled. Pullbacks need to be modified to 
match the defined 𝑦 data type by segmenting the struts and assigning the depth to the A-
scans and assigning zero to A-scans with no strut. The presence of a guide wire, however, 
will complicate the optimization as it casts a shadow for each revolution and the 
corresponding A-scans do not convey any information about stent reflection.    
Using pullback data to initialize catheter parameters  
Catheter position and orientation can be estimated from IVOCT images and 
specified as initial values. Catheter position with respect to arterial wall is located since it 
is at the center of IVOCT images. Average of catheter position over few frames provides 
initial values of 𝑥𝑐 and 𝑦𝑐 . Change in catheter position over the entire pullback can provide 
an estimate of 𝜑𝑐 and 𝜃𝑐. Defining initial values of parameters will decrease computation 
time and improve the value of 𝜒2.   
Incorporating vessel tortuosity and luminal area variation 
The simulated pullback at present is generated assuming stent is deployed in a 
straight vessel with constant luminal area and therefore can be applied only IVOCT 
pullbacks of phantom vessels. Coronary arteries are tortuous and luminal area varies along 
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the stented length of the artery, especially in presence of atherosclerotic plaques. Simulated 
pullback will be modified to include bends and variation in cross sectional area.    
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